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This research utilized stereovision body imaging (SBI) as a method for 
determining total, central and regional body composition. In Aim 1, prediction equations 
for abdominal adiposity were developed via anthropometrics, SBI, and magnetic 
resonance imaging. R2 for total abdominal, subcutaneous, and visceral adiposity were 
89.9%, 90.4% and 71.7%, respectively. The prediction of visceral fat was improved when 
SBI was included as a method. In Aim 2, body size and shape of men and women, as well 
as risks associated with accumulation of visceral adiposity, were determined by body 
measurements via SBI. Men had higher total body, torso and abdomen-hip volumes and 
waist circumference, while women exhibited greater thigh volume, hip circumference, 
and lower body-volume ratios (p<0.05), while the BMI values for men and women did 
not differ (p>0.05). Thigh to torso [odds ratios (OR) 0.44] and abdomen-hip (OR 0.41) 
volume ratios were associated with decreased risks of accumulating visceral adiposity. 
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SBI was effective for determination of body size and shape and the prediction of visceral 
adiposity accumulation in adults. In Aim 3, the efficacy of body measurements assessed 
by SBI was explored for the determination of android and gynoid body fat via SBI and 
dual-energy x-ray absorptiometry. The R2 of the mathematical equations established by 
body measurements assessed via SBI for fat mass and percent body fat were 93.2% and 
76.4% for android, and 91.4% and 66.5% for gynoid, respectively. These prediction 
values indicate that SBI is good for estimation of android and gynoid body fat mass; but 
less effective for percent body fat. An improved understanding of human body 
composition was achieved by this research.  
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1 
CHAPTER 1. INTRODUCTION 
 
Obesity is a significant epidemic health problem associated with diseases such as 
hypertension, dyslipidemia, coronary heart disease, and type 2 diabetes (1-4). Other 
unfavorable effects of obesity include negative body image, negative self-esteem, and 
poor health-related quality of life (5-7). The prevalence of obesity in the United States is 
an epidemic, as 33.3% of adults are overweight [body mass index (BMI) 25-29.9 kg/m2], 
34.9% are obese class I and II (BMI 30.0-39.9 kg/m2), and 6.6% are obese class III (BMI 
! 40 kg/m2) (8-10). 
To date, BMI is the most commonly used method to determine body size and 
shape that reflects overall obesity status. The classifications of BMI are generally divided 
into six categories: underweight (BMI <18.50 kg/m2), healthy weight (BMI 18.5-24.99 
kg/m2), overweight (BMI 25-29.99 kg/m2), obese class I (BMI 30-34.99 kg/m2), obese 
class II (BMI 35-39.99 kg/m2), and obese class III (BMI ! 40 kg/m2) (11, 12). Values of 
! 30.0 kg/m2 are documented to be associated with increased risks of developing 
hypertension, dyslipidemia, cardiovascular disease, type 2 diabetes, and metabolic 
syndrome (13-17). Thus, BMI is ideal for epidemiological and preliminary screening in 
clinical and field settings. However, the sensitivity involved with screening populations 
by this method is relatively crude because the index is oversimplified. It is limited in 
differentiation of muscle and fat mass, as well as android and gynoid shape between 
individuals (18-20).  
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Current methods to determine total, central, and regional body compositions have 
numerous shortcomings, such as high expense, non-portability, or lack of 
accuracy/availability. Consequently, newer instruments and techniques are needed to 
create more practical methods for assessing and monitoring different types of obesity.  
Total body fat mass and percentage are utilized mainly to determine overall 
obesity status. Central obesity measures include surrogate measurements of abdominal 
adiposity, such as: waist circumference, sagittal diameter, waist-to-hip ratio, waist-to-
height ratio, and skinfold thickness, as well as direct measurements of abdominal 
adiposity (total abdominal, subcutaneous, visceral fat, and android fat). Other body 
measurements used to assess regional obesity include: arm fat, gynoid fat, thigh 
circumference, thigh fat, sagittal abdominal diameter to thigh circumference ratio, and leg 
length, volumes, fat, and leg to trunk fat ratio. 
 This research will discuss the obstacles in using existing instruments and methods 
to measure overall, central, and regional obesity and provide a better solution for 
detection of body composition. The primary objective of this study was to enhance 
assessment of total, central, and regional body composition by comparing a three-
dimensional (3D) stereovision body imaging (SBI) system, versus the “gold standards” of 
air displacement plethysmography (ADP), dual-energy x-ray absorptiometry (DXA), and 
magnetic resonance imaging (MRI).  
 
Approaches for Specific Aims 
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Aim 1. To develop mathematical models for the prediction of total abdominal, 
subcutaneous, and visceral adiposity using measurements derived via SBI.  
Hypothesis: Body measurements obtained by a SBI will serve as accurate determinants 
for prediction of total abdominal, subcutaneous, and visceral adiposity. 
Rationale: Mathematical models derived from measurements obtained by SBI can be 
predictors of abdominal adiposity with the application of newly developed technology. 
SBI can be utilized for predicting the presence and type of abdominal fat in clinical and 
field settings. This information will aid physicians and health providers to make better 
informed decisions regarding the risks of abdominal adiposity. 
 
Aim 2. To determine the body size and shape via a SBI system assessed total/regional 
body volume and volume ratios in men and women. 
Hypothesis: Total/regional body volumes and volume ratios measured by SBI are 
accurate measurements for determination of body size and shape in men and women.  
Rationale: SBI is a reliable instrument that utilizes a precise and valid method for 
assessing total and regional body volumes. Body volume ratios, including the upper- and 
lower-body volume, can reflect the body size and shape of men and women. This 
stereovision instrument will serve as a useful tool for clinical and field studies as a rapid, 
non-invasive, objective method of obesity assessment.  
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Aim 3. To examine the efficacy of SBI for assessment of regional body fat distribution, 
including android and gynoid fat mass and percentages. 
Hypothesis: Regional body fat can be estimated effectively by the use of SBI. This 
system will provide a more accurate analysis of regional body fat, volume, and 
circumferences more easily and at a lower cost than other instruments currently available.  
Rationale: Determination of the total body volume or percent fat of an individual is 
oversimplified and lacks information on regional fat distribution. The distribution of fat 
in different regions of the body can influence health risks in relation to chronic diseases. 
Current methods for measuring body fat regions are expensive and not convenient when 
compared to the relative cost effectiveness and ease-of-use of a SBI system. It is 
estimated that the SBI system will market for ~$10,000, as opposed to the much higher 
costs of CT, DXA and MRI. It is believed that SBI will be an accurate measurement of 
both android and gynoid fat mass and percent body fat. 
 
Assessment of Overall Obesity 
A wide variety of methods are used to estimate overall obesity, including: 
traditional anthropometrics, bioelectrical impedance analysis (21), hydrodensitometry 
(22), abdominal ultrasonography (23), ADP or BOD POD® (24), DXA (25), computed 
tomography (CT) (26), and MRI (27).  
Traditional anthropometric measurements achieved by manual methods are the 
most commonly utilized because they are practical, cost-efficient and the least difficult to 
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obtain. Weight and height are measured primarily to calculate BMI, which provides an 
estimation of overall weight status. Skinfold thickness (28, 29) is an older procedure that 
utilized interrelationships among subcutaneous fat, internal fat, and whole body density 
to determine overall obesity. Other anthropometric indices (30-33) predict percent body 
fat from circumferences and skeletal diameters, but the predictive accuracy of equations 
is not improved greatly by adding measures of skinfold thickness. Waist circumference is 
the most significantly related to health risks (34, 35), as it reflects central obesity. In 
addition, sagittal diameter, a measure of anteroposterior thickness of the abdomen at the 
umbilicus (36), may be an indirect measure of visceral fat (37, 38). However, manual 
methods are known to be problematic in inter rater reliability (39).  
The technique of bioelectrical impedance analysis utilizes the contrast of electric 
impedance of tissues (40, 41). The aqueous tissues are suitable conductors due to their 
dissolved electrolytes; whereas, fat and bone have relatively poor conductance properties. 
Consequently, this device provides body fat percentage by estimating fat free mass (or 
total body water) from measurements of impedance and reactance (40, 41). However, the 
percent fat value may vary according to the hydration status of individuals, thus limiting 
its usefulness in severe obesity (42). 
Hydrodensitometry was once considered the gold standard for assessment of body 
fat. It is based on body density, estimated by measuring total body volume from water 
displaced when the body is fully submerged. If the body is assumed to be composed of 
two components, including fat and fat-free mass with known densities, then the percent 
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body fat can be calculated from body density by equations such as Siri, Brozek, Lohman, 
Ortiz, and Schtte (43-47). The principle of hydrodensitometry is simple and it is the 
oldest established method to estimate body density, as it has been in existence since 1945 
(48). However, this method is not suitable for the elderly and children due to severe 
subject burden, such as the stress of being submerged repeatedly in a small enclosure of 
water, the inability to climb into a tub, and having to bend forward and exhale while in a 
small space under the water (49, 50). 
Abdominal ultrasonography is one of the methods that is capable of assessing 
abdominal adiposity by incorporating transducer (probe), transmission (gel) and high-
frequency sound waves to capture the image of the abdominal anatomical structures (i.e. 
organs and blood vessels) (51). Visceral adiposity assessed by ultrasonography was 
closely linked with metabolic risk factors, such as homeostasis model assessment 
(HOMA) index (r=0.41, p<0.001). These associations were stronger than subcutaneous 
adiposity assessed by ultrasonography (r=0.17, p<0.05) (52). The reproducibility of 
measuring abdominal adiposity is relatively high with ultrasonography, as the coefficient 
of variation was 0.8%, as reported by Ribeiro-Filho et al. (2004) (23). Moreover, the 
utilization of abdominal ultrasonography is beneficial compared to CT or DXA due to the 
fact that it is not associated with ionizing radiation. Yet, the diagnostic concordance for 
visceral adiposity was only 74% when compared to CT. This indicates that 
ultrasonography cannot be considered as an accurate means to assess visceral adiposity 
(23).  
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ADP (or BOD POD®) is a newer method that displays good agreement for percent 
body fat compared with DXA (within 1%) (53). It is more accommodating in that it is 
less difficult for the subject than hydrodensitometry (53, 54). This system is based on 
theoretical constructs of Dempster and Aitkens (55), and the methods of Ginde et al. (24). 
Under isothermal conditions, body density is estimated in a specially designed capsule 
via variations in pressure and body volume. The breathing circuit system measures 
thoracic gas volume while the subject breathes normally. Five prediction equations (Siri, 
Brozek, Lohman, Ortiz, Schtte) are available in the BOD POD® software in order to 
measure percent body fat for different populations, including the general population (44), 
African American males (47), African American females (46), lean and obese individuals 
(56), and children under 17 years old (45). These prediction equations are based on 
measurements of body volume and body mass to estimate fat and fat-free mass. In 
comparison to hydrodensitometry, this method underestimates body fat percentage in 
men, yet it overestimates body fat percentages in women, perhaps due to their excess 
body hair (57). Body density measured via ADP was significantly correlated with 
hydrodensitometry (r=0.94, p<0.001) (54). But, measurements generated using this 
technique can be influenced by alterations in body temperature. Also, it requires the 
subject to remain still (for ~ 100 seconds) which may be difficult for children. This 
technique can induce claustrophobia due to the small size of the chamber (24). 
Instruments that utilize advanced techniques and are capable of assessing detailed 
information include DXA (58), CT (59), and MRI (60). DXA differs from 
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hydrodensitometry and ADP in that it is a three-compartment model of body composition 
estimation, which is based on assumptions concerning the absorption of x-rays by bone, 
non-bone lean tissue or protein, and fat (61). The separation of fat-free mass into protein 
and bone mass increases accuracy because it accounts for inter-individual variations in 
these components. This device uses a technique based on different attenuations of X-rays 
through bone, lean tissue, and fat that decline with increasing photon energy (58, 62). The 
amount of tissues is estimated by the transmittance rates of X-rays at varying energies. 
This system is known to be accurate for measurement of bone mass, but it can 
underestimate percent body fat by 2-4%, and fat mass by 1.9 kg, as compared to 
hydrodensitometry (63). It also has been reported that DXA overestimates fat mass and 
body fat (64). Presumably, the bias that exists in DXA is due to variations in body size, 
fat mass, sex, and disease state. In addition, this method is limited because instruments 
have a weight and size limit. For example, some instruments have a weight limit of 300 
lbs (GE/Lunar Prodigy densitometer, software version 10.5); other instruments are 
limited to 250 lbs (50, 53). Moreover, values for DXA differ according to the 
manufacturer, scanner, and software-specific algorithms, yielding higher (53, 65-67) and 
lower measurements (49, 68, 69) than comparable methods. Nonetheless, DXA has been 
reported to be sensitive for assessing moderate weight loss (64).  
 Both CT and MRI estimate body composition by imaging internal body 
structures. CT measures the differences in the attenuation of computer programmed X-
rays through the tissues. It creates cross-sectional 3D slices to capture detailed images of 
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the body, such as brain, internal organs, and fat tissues. (59). MRI utilizes radio waves in 
the magnet fields, and measures the abundance of hydrogen nuclei in different tissues. 
This technique results in the production of high quality, 3D anatomic images without the 
risks of ionizing radiation (70). Both DXA and CT involve the use of radiation during the 
assessment. In addition, ADP, DXA, CT, and MRI are limited in their practical use due to 
their lack of portability, large size, and high expense associated with these devices, which 
limits practicality for large population studies.  
 
Determination of Central Obesity  
In the assessment of obesity, measurement of central obesity may be just as 
important as determination of overall adiposity (71-74). Central obesity is defined as 
excess fat around the abdominal area. Assessment of central obesity is complicated by the 
fact that there are three basic types of fat within this area, including subcutaneous 
adiposity (abdominal fat depots underneath skin), visceral adiposity (abdominal fat 
depots around organs), and ectopic fat (fat depots in locations not associated with 
accumulation of adipose tissue) (75). Excess subcutaneous fat is associated with insulin 
resistance (9,10) and cardiovascular disease risk factors (76). An abundance of fat 
accumulation within the visceral area has been linked to diabetes (77), hypertension (78) 
and metabolic syndrome (71). Finally, ectopic fat (i.e. liver fat) is associated with 
obesity-related vascular and coronary artery disease (79, 80). Abdominal visceral 
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adiposity is widely classified as part of ectopic fat because it is not supposed to 
accumulate in this area (81).  
In the abdominal fat depots, a preponderance of evidence supports that abdominal 
visceral fat has greater implications for diabetes-related risk factors, as compared to 
abdominal subcutaneous adiposity (71, 74, 82-84). However, assessment of abdominal 
adiposity, especially visceral adiposity, is difficult because it requires instruments that 
utilize advanced techniques, such as MRI or CT; whereas, subcutaneous adiposity can be 
measured by traditional anthropometric methods (i.e. skinfold thickness). 
It is recognized that over-accumulation of visceral fat tends to act as a 
dysfunctional adiposity that induces excess storage of ectopic fat (muscle, epicardial, and 
liver fats) (82). Consequently, abnormal free fatty acid metabolism may trigger the 
dysfunctional release of adipokines (82). Accumulation of the ectopic fats influences the 
metabolic profile and, eventually, increases the risks of developing metabolic syndrome 
(82). In contrast, subcutaneous fat is characterized by some as a “healthy adiposity,” 
which does not appear to influence the development of metabolic syndrome (82). Thus, 
assessment of visceral adiposity may be more important for ascertainment of health risks, 
as compared to prediction of subcutaneous adiposity. 
Traditional anthropometric measurements achieved by manual methods are 
utilized to a great extent because they are practical, cost-efficient and the least difficult to 
obtain. Those that reflect central obesity include waist circumference (85, 86), sagittal 
abdominal diameter (87, 88), waist-to-hip ratio (85, 89), waist-to-height ratio (90), and 
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skinfold thicknesses (86). Waist circumference is the most commonly used surrogate 
measurement of central obesity because it is simple to obtain. In addition, it demonstrates 
a high correlation with visceral adiposity volume (r=0.87), as compared to waist-to-hip 
ratio (r=67) (87). Greater waist circumferences than 102 cm in men and 88 cm in women 
are associated with a substantial increase of metabolic dysfunctions (91). For example, a 
larger waist circumference is related to increased metabolic disease risks (91), diabetes 
(92), cardiovascular diseases (93), and mortality (94). Sagittal diameter is a measure of 
anteroposterior thickness of the abdomen at the umbilicus in the supine position (95). 
Previously this measure has been shown to be an effective predictor of visceral adiposity 
in adults (96), but not in adolescents (97). Sagittal abdominal diameter is utilized as a 
surrogate of abdominal adiposity, as it is demonstrated to be a consistent predictor of 
cardiovascular disease. The hazard ratio for men and women was 1.42 and 1.44, 
respectively (98). Moreover, sagittal abdominal diameter was strongly related with 
cardiovascular risk factors (95, 99) and metabolic syndrome (100), even compared to 
waist circumference. Yet, Valsamakis et al. (2004) demonstrated that waist 
circumference showed stronger associations with visceral adiposity, as compared to 
sagittal diameter (101). 
Waist-to-hip ratio is another of the most commonly used measurements for 
estimation of central obesity. The cut-off points for waist-to-hip ratio for predicting 
greater metabolic implications indicated by the World Health Organization (WHO) are 
0.90 cm for men and 0.85 cm for women (91). Along with waist circumference, waist-to-
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hip circumference showed strong associations with cardiovascular risk factors (93), type 
2 diabetes (102), hypertension, and overall mortality (103). Waist-to-height ratio was 
introduced in the 1990s for detecting abdominal obesity and related health risks (104). 
Previously, waist-to-height ratio has been previously reported as a better predictor for 
cardiovascular diseases (105) and diabetes (106), as compared to waist-to-hip ratio or 
BMI. Waist-to-height ratio was more effective for predicting cardiometabolic risk than 
either waist circumference or BMI (90). Furthermore, waist-to-height ratio is utilized as 
an index of central obesity, which is more effective in defining metabolic syndrome than 
waist circumference (107).  
Manual methods have potential for errors in inter rater reliability. For example, 
measurements can differ depending on the amount of training undertaken by the measurer 
for both waist and hip circumferences (108), and skinfold thickness (109). Furthermore, 
protocols for anthropometric measurements may not be consistent across different 
investigations and have not resulted in reliable outcomes (39, 110-113). In a literature 
review, Wang et al. (2003) found 14 different descriptions in three different manuals used 
as reference guides for the measurements of waist circumference (39).  
Mason and Katzmarzyk (2009) explored the impact of the four major 
measurement sites of waist circumference on prevalence of metabolic syndrome (110). 
These include the superior border of the iliac crest, midpoint between the iliac crest and 
the lowest rib, and the umbilicus, and smallest circumference of the waist (110). 
Associations with morbidity/mortality (112) and abdominal adiposity (subcutaneous and 
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visceral fat) differed (113), depending on the sites or the protocols used to assess the 
body measurements. Thus, traditional anthropometric parameters appear to be an 
imprecise means for the accurate measurement of central obesity (39, 111). 
Finally, the problem of awkwardness resulting from the close proximity between 
the researcher and subject remains when obtaining anthropometric data by manual 
methods. Devices such as abdominal BIA or ultrasonography (23, 114) are alternatives to 
assess central obesity in a cost-efficient and uncomplicated manner. Nonetheless, BIA is 
sensitive to hydration status and body geometry (in which water distribution differs), 
which may be limiting its usefulness in severe obesity (54). Previously, abdominal 
ultrasonography showed only 74% of the diagnostic concordance compared to CT (23). 
Thus, BIA or ultrasonography may not be as an accurate assessment tool for visceral 
adiposity, as opposed to MRI or CT, which directly assess the fat mass in the abdominal 
area and differentiate subcutaneous and visceral adiposity. 
 
Evaluation of Regional Obesity  
 The overall fat distribution of humans can be classified crudely into android (apple 
shape or upper-body obesity) or gynoid (pear shape or lower-body obesity) shapes (115, 
116). An android body shape is more closely linked with increased metabolic 
dysfunction, as opposed to a gynoid body type. Accumulation of body adiposity in the 
upper or lower regions has a more significant association with adverse metabolic 
functions (117). Specifically, greater fat accumulation in the lower body region is 
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believed to be protective. In contrast, fat depots in the upper region are more closely 
linked to obesity-related conditions, such as elevated insulin and glucose levels (118-
121), metabolic dysfunctions (122-124), and greater risks of cardiovascular disease (123, 
125, 126) and diminished longevity and mortality (123, 127). Knowledge of specific 
shapes and sizes of bodies and segments, with varying distribution of regional fat 
distribution, may provide beneficial information for clinical applications.  
 Measures of lower body fat have been explored previously by other researchers 
including hip and thigh circumference, thigh fat, leg fat, and gynoid fat (118-121). 
Greater waist circumference and smaller hip circumference were observed in type 2 
diabetic patients, as compared to healthy participants, regardless of age, lifestyle factors, 
and intensity of obese status (as classified by BMI) (128). Both hip and thigh 
circumferences were inversely related to type 2 diabetes risks (32). Especially, thigh 
circumference was associated with positive levels of glucose in women (33). 
Furthermore, thigh adiposity was negatively linked to metabolic syndrome in elderly 
obese adults (9), a higher presence of glucose in men, and increased levels of glucose and 
lipids in men and women (33). Moreover, leg adiposity was related to low levels of 
glucose (34).  
Aasen et al. (2008) noted that greater leg fat, as compared to trunk fat assessed by 
DXA, was associated with reduced insulin resistance in obese (120) and  obese 
postmenopausal women (p<0.05) (83). Similar associations were identified with 
cardiometabolic variables (blood pressure, insulin resistance, high density lipoprotein, 
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triglycerides, high-sensitivity C-reactive protein) in healthy postmenopausal women 
(124). Similarly, positive relationships exist between larger waist and smaller hip 
circumferences and elevated cardiovascular disease risk factors (129). In addition, greater 
leg fat mass (kg) compared to whole body fat mass (kg) or trunk fat mass (kg), that was 
assessed by DXA, were associated with decreased metabolic risk factors (blood pressure, 
cholesterol, low and high density lipoprotein cholesterol, triacylglycerol, fasting blood 
glucose and serum insulin, C-reactive protein) in Caucasians, African Americans, and 
Hispanic men and women (p<0.05) (130). Gynoid fat, as determined by DXA, 
demonstrated decreased odds of metabolic risk factors, including blood pressure [odds 
rstios (OR) 0.5, p<0.01], fasting plasma glucose (OR 0.5, p<0.01) and triacylglycerol 
(OR 0.6, p<0.01) (131). Thus, assessment of specific regional body composition may be 
just as essential as determination of overall obesity.  
The limitations of using regional body measurements obtained via traditional 
anthropometrics, MRI, CT, or DXA are similar to those associated with the assessment of 
central obesity. These measures are inaccurate, invasive, non-portable, expensive, or 
inefficient. Thus, alternative instruments are needed for the assessment of regional body 
composition. 
 
System of Stereovision Body Imaging 
Alternative methods that provide more practical and cost efficient means for 
obtaining accurate body measurements are essential for researchers and practitioners 
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because of the limitations of current measures to assess total, central, and regional 
obesity. To address issues of reliability and accuracy, 3D body scanners have been 
utilized for obtaining body images and measurements (46, 30). Previous studies confirm 
that 3D body scanners are efficient and reliable instruments that can replace some 
traditional manual methods to accurately measure body circumferences (47-49). 
Moreover, the 3D surface imaging of the human body has received considerable attention 
due to its broad range of applications, such as in the clothing industry (132, 133), movies 
and computer games (117), biometrics (134), dermatology and cosmetics (135), and 
breast and plastic surgery (136, 137). In recent years, this technique has been employed 
for obesity assessment due to the fact that the technique is easy to use, safe, and cost-
effective (138).  
Previous photonic body scanners have been used to measure body composition 
and compare body size and shape of different populations. The SBI incorporated in this 
study was validated for accuracy in measuring body volume and percent body fat, as the 
difference between ADP and SBI for assessing body volume was only "0.165 ± 0.692 
(p=0.30) and 0.789 ± 4.178 for percent body fat (p=0.41) (138). The Hamamatsu 
Bodyline Laser Scanner was validated initially in adults and children to measure body 
volume. It showed less than a 3% error for assessment of body volume, as compared to 
that measured by underwater weighing and ADP. These results confirmed the accuracy of 
the system (139). Subsequently, a 3D photonic scanner [TC]2 was utilized to assess body 
circumferences, including head, mid-upper arm, chest, waist, hips, mid-thigh, knee and 
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calf in diverse populations (American, British, Thai) (140-143). Values of body 
circumference ratios also were explored, according to different sex and age categories, in 
order to determine the disparities of body size and shape (142). The body measurements 
obtained via a Chang Gung Total Body Scanner determined relationships with BMI, 
somatotype index, and anthropometric data (144). Based on these data, a health index 
(145, 146) was developed with an anthropometric chronic disease risk factor score (147). 
This health index will allow clinicians to identify health risks.  
The SBI system that was utilized in this research was designed and assembled by 
Dr. Bugao Xu at the University of Texas. It is a novel device that is capable of providing 
specific body measurements, including volumes for total body, torso (neck to umbilicus), 
abdomen-hip (umbilicus to hip), and thigh (crotch to top of knee); circumferences of 
shoulder (widest girth of upper torso including arms), chest (widest girth of chest), 
abdomen (smallest girth of torso), hip (widest girth of lower torso), crotch (lowest point 
of torso), upper thigh (highest point of thigh), lower thigh (lowest point of thigh), knee 
(bottom of knee), and calf (widest girth of lower leg); length of front and back (neck to 
waist), front and back upper torso (shoulder to waist), lower torso (umbilicus to crotch), 
crotch (abdomen to crotch), front and back shoulder slope (diagonal shoulder to waist), 
and thigh (crotch to top of knee); and breadth at the shoulder (138, 148). This device has 
been validated against ADP to accurately measure body volume and body fat percentage, 
as the differences were " 0.165 ± 0.692 (p=0.30) for fat mass and 0.789 ± 4.178 for 
percent body fat (p=0.41) (138). Moreover, the visual representation of a human body 
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provided by the SBI improves the assessment of body size and shape in men and women 
because it can be rotated 360º in all directions (Figure 1.1).  
The amount of time required to perform the measurement via SBI is brief, as the 
subject remains motionless for only 200 milliseconds per scan. More than 1 million data 
points are acquired, with a resolution under 1 mm. Less than 1 minute of processing time 
is required for surface modeling, during which a 3D image with numerous body 
circumferences at desired landmarks is generated (138, 148). An additional advantage of 
using a 3D stereovision device is that it is relatively inexpensive and much more portable 
than cumbersome equipment, such as DXA and ADP. This device has been validated for 
assessment of body volume and fat in 10 men and 10 women, as compared to ADP (138).  
An innovation of SBI is that it measures central obesity utilizing two new 
parameters: central obesity width and central obesity depth (149). The definition of 
central obesity width is a measurement of the largest width on the coronal plane, at the 
level of the umbilicus. Central obesity depth is the length between the mid-point of the 
central obesity width and umbilicus. The two measurements lie perpendicularly on the 
same plane. It is believed that these surrogate measurements of central obesity will be 
effectively utilized for the assessment of central adiposity. 
 In sum, the current research was undertaken to explore the efficacy of a 3D SBI 
system as an instrument for determining total, central, and regional obesity in order to 
provide a more accurate and efficient means for obesity assessment and monitoring. It is 
believed that this newly developed state-of-the-art SBI will be effective for the 
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assessment of total, central and regional adiposity. The ability to accurately estimate body 
adiposity will provide health practitioners an enhanced ability to assess and monitor types 
of obesity. 
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Figure 1.1. Diverse body sizes and shapes of men and women determined by a three-dimensional stereovision body imaging 
system  
(a) Men, starting from the left side, BMIs are 20, 24, 29, 36, 40 kg/m2, respectively. 
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 (b) Women, starting from the left side, BMIs are 19, 25, 30, 35, 39 kg/m2, respectively. 
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CHAPTER 2. PREDICTIVE EQUATIONS FOR CENTRAL OBESITY VIA 
ANTHROPOMETRICS, STEREOVISION IMAGING, AND MAGNETIC 
RESONANCE IMAGING IN ADULTS1 
Abstract 
Abdominal visceral adiposity is related to risks for insulin resistance and 
metabolic perturbations. Magnetic resonance imaging (MRI) and computed tomography 
are advanced instruments that quantify abdominal adiposity; yet field use is constrained 
by their bulkiness and costliness. The purpose of this study is to develop prediction 
equations for total abdominal, subcutaneous, and visceral adiposity via anthropometrics, 
stereovision body imaging (SBI), and MRI. Participants (67 men and 55 women) were 
measured for anthropometrics, and abdominal adiposity volumes evaluated by MRI 
umbilicus scans. Body circumferences and central obesity were obtained via SBI. 
Prediction models were developed via multiple linear regression analysis, utilizing body 
measurements and demographics as independent predictors, and abdominal adiposity as a 
dependent variable. Cross-validation was performed by the data-splitting method. The 
final total abdominal adiposity prediction equation was – 470.28 + 7.10 waist 
circumference – 91.01 sex + 5.74 sagittal diameter (R!=89.9%); subcutaneous adiposity 
was – 172.37 + 8.57 waist circumference – 62.65 sex – 450.16 stereovision waist-to-hip 
ratio (R!=90.4%); and visceral adiposity was – 96.76 + 11.48central obesity depth – 5.09 
central obesity width + 204.74 stereovision waist-to-hip ratio – 18.59 sex (R!=71.7%). R! 
                                                
1 Portion of this chapter has been published in Obesity (Silver Spring) (149) “Lee JJ, Freeland-Graves JH, 
Pepper MR, Yao M, Xu B. Predictive equations for central obesity via anthropometrics, stereovision 
imaging and MRI in adults. 2014;22:852-62.” 
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significantly improved for predicting visceral fat when SBI variables were included, but 
not for total abdominal or subcutaneous adiposity. SBI is effective for predicting visceral 
adiposity and the prediction equations derived from SBI measurements can assess 
obesity.  
 
Introduction 
Obesity is a significant health problem associated with diseases, such as diabetes 
(150), coronary heart disease (4), and nonalcoholic fatty liver (151, 152). In the United 
States, approximately 34.2% of the population is overweight [body mass index (BMI) ! 
25.0 to 29.9 kg/m2], and 33.8% and 5.7% exhibit obesity (BMI ! 30.0 to 39.9 kg/m2) or 
extreme obesity (BMI ! 40 kg/m2), respectively (152).  
The most common method to classify the degree of weight status is BMI, due to 
its simplicity. Since values ! 30.0 kg/m2 are linked to greater mortality and morbidity in 
populations, this method is ideal for epidemiological and preliminary screening in clinical 
and field settings. However, BMI does not distinguish between those with high muscle 
mass versus high fat, or the distribution of fat in different regions of the body. The 
distribution of fat is important, as excess subcutaneous fat (underneath the skin) is related 
to insulin resistance (153) and cardiovascular disease risks (76). In contrast, an 
abundance of visceral fat (between/around the organs) is associated with diabetes (77), 
hypertension (78), and metabolic risk factors (71).  
Traditional anthropometric measurements ascertained by manual methods are the 
most commonly utilized for obesity assessment because they are practical, cost-efficient, 
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and the least difficult to obtain. Measurements that reflect central obesity may include 
waist circumference (86), waist-to-hip ratio (89), skinfold thicknesses (86), and sagittal 
diameter (88).  
Investigations of anthropometric measurements and risk for obesity-related 
diseases have shown that waist circumference and waist-to-hip ratio are positively related 
to coronary heart disease in women (89); and that greater waist circumference and 
thickness of abdominal skin folds are associated with increased risk for metabolic 
syndrome (154). Also, sagittal diameter appears to be more related to cardiovascular risk 
factors than waist circumference or waist-to-hip ratio (95).  
Manual body measurements are readily accessible, but their accuracy may be 
subject to low inter-rater reliability, inadequacy of training, and variances in the type of 
methods utilized (108). For example, Wang et al. (2003) reported 14 different 
descriptions in three different manuals used as reference guides for measurements of 
waist circumference (39). In addition, awkwardness is created by the close proximity 
between researcher and subject. Thus, traditional anthropometric parameters are an 
imprecise means for accurate measurement of abdominal adiposity. It is clear that devices 
that incorporate advanced techniques, such as magnetic resonance imaging (MRI) or 
computed tomography (CT) may provide more precise assessment (71). Yet, the large 
size and high expense associated with these instruments limit their use in field settings. 
Furthermore, the utilization of dual-energy x-ray absorptiometry (DXA) and CT may be 
precluded by the risk of radiation exposure. 
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A further step in the assessment of obesity can be the application of mathematical 
prediction equation models. Traditionally, these models have been developed by 
combining manual anthropometric measurements (weight, height, BMI, waist-to-hip 
ratio, sagittal diameter, body circumferences, skinfold thicknesses) and demographic 
characteristics (age, sex, ethnicity) (155, 156). However, the final prediction model is 
only as precise as the accuracy of the measurements inputted.  
This research will test the efficacy of using a method of photogrammetry to be 
incorporated into prediction models for assessing central obesity. To date, 3D body 
scanners have been utilized for obtaining body images and measurements (138). These 
scanners are reliable instruments that can replace manual methods to accurately measure 
body circumferences (142, 157). This technique has been proven useful for tailoring 
clothing for textile manufacturing purposes, as well as for the assessment of obesity 
(138). The present study will utilize a SBI system to acquire fast, noncontact 3D whole 
body images and measurements, in order to develop algorithms for prediction of total, 
subcutaneous, and visceral abdominal adiposity. Parameters measured by SBI also will 
include unique measurements of central obesity, such as central obesity depth and central 
obesity width. Three variations of measurements will be tested: traditional 
anthropometrics, SBI, and a combination of the two. Accuracy between the prediction 
models will be compared to determine the best methods for prediction of central obesity.  
 
Method and Procedures 
Design of Study  
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The convenience sample consisted of 122 adults who were instructed to fast for 4 
hours and avoided heavy exercise, alcohol or caffeine for 10 hours prior to the visit. 
Subjects made two visits to the: 1) university laboratory and 2) MRI research center.  
At visit 1, demographic and health history questionnaires were completed and 
subjects were assessed for traditional anthropometrics measurements, including weight, 
height, body circumferences, and sagittal diameter. Body scans were performed via SBI 
to assess body size, shape, circumferences, composition, and central obesity. At visit 2, 
MRI scans were obtained for assessment of central adiposity measurements. To minimize 
errors, all measurements were completed at the laboratory within 3 hours and MRI 
assessment was made within 5 days. 
 
Subjects  
Hispanic and Non-Hispanic White men (n=67) and women (n=55) were recruited 
for the study via posted notices and word-of-mouth. Participants were aged 18 to 65 years 
old, with BMI ranging from 18.5 to 39.9 kg/m2. Subjects were excluded from the study 
for any serious illness that could interfere with their ability to participate. Additionally, 
individuals who had exposure to metallic fragments or implants were eliminated due to 
the risks involved with utilizing MRI. Women who were or could be pregnant, or were 
lactating also were excluded due to university regulations. The study was approved by the 
University of Texas at Austin Institutional Review Board.  
 
Anthropometrics 
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Standard protocols for the anthropometric measurements established by the 
National Institutes of Health guidelines (NIH guidelines) were performed by trained 
nutrition experts. Subjects were measured for height in centimeters to the nearest 0.1 
centimeter without shoes and socks by a stadiometer (Health o meter, South Shelton, 
CT), and weight in kilograms by an electronic scale (Tanita, Arlington, IL) to the nearest 
0.01 kilogram. Body circumferences, including arm, waist, hip, and thigh circumferences, 
were assessed via a MyoTape body tape measure (AccuFitness, Greenwood Village, CO). 
Sagittal diameter was measured horizontally from the umbilicus to the back via an 
abdominal caliper (Lafayette Instrument, Lafayette, IN). BMI was calculated by weight 
(kg) divided by height (m2). Waist-to-hip ratio was computed by waist circumferences 
(cm) divided by hip circumferences (cm) and measurement for waist-to-height ratio was 
obtained by waist circumferences (cm) divided by height (cm).  
 
System of Stereovision Body Imaging 
 Participants wore light-colored undergarments to facilitate accurate measurement of 
body size and shape with a swimming cap to conceal hair, and a blindfold to protect the 
eyes from the lights of the projectors. Subjects were instructed to place both arms at their 
sides with elbows bent, making a fist with both hands, with arms placed about 10 cm 
away from the body. Legs were spread approximately shoulder-width apart. Each subject 
remained motionless and was asked to hold their breath for 1 second during the 200-
millisecond body scan. A total of 10 body scans were obtained to acquire the mean value.  
 The SBI system was fabricated with four pairs of monochromatic CMOS cameras 
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(Videre Design, Menlo Park, CA), with a resolution of 1280 ! 960, and four ultrashort 
throw NEC 575VT LCD projectors (NEC Corporation, Tokyo, Japan) (138). Projectors 
were required to generate artificial texture on the scanned surface since human skin is not 
rich in texture. Four pairs of cameras simultaneously captured the body image when the 
body was illuminated by the projectors. The SBI is a novel device that calculates specific 
body measurements, including volumes, length, breadth, and central obesity parameters, 
via a rapid and non-invasive method. It can be assembled in a relatively small space and 
provides visual representation of body size and shape that can be rotated 360º in all 
directions. Advantages of this system over CT or MRI are: a) portability, which allows it 
to be used in field setting; b) cost, which is much lower than other equipment available; 
and c) lack of radiation. 
SBI measurements included: shoulder, chest, abdomen, hip, crotch, upper thigh, 
lower thigh, knee, and calf circumferences, as well as central obesity depth and central 
obesity width. Central obesity width was defined as the largest width on the coronal 
plane, at the level of the umbilicus. Central obesity depth is the length between the mid-
point of the central obesity width and umbilicus. These two measurements lie 
perpendicularly on the same plane (Figure 2.1).  
Measurements for ratios computed were SBI waist-to-hip (waist circumference 
divided by hip circumference), waist-to-thigh (waist circumference divided by thigh 
circumference), and waist-to-height (waist circumference divided by height). 
 
Magnetic Resonance Imaging 
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Figure 2.1. Central obesity depth (COD) and central obesity width (COW) at the umbilicus level, with minimal subcutaneous 
at the nearest site 
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Participants were scanned for MRI via a 3.0 T general Electric scanner (GE Healthcare, 
Milwaukee, WI). When each subject was positioned on the center of the magnet, a 4-
second 3-plane localizer scan was conducted, allowing visualization of anatomical 
landmarks. A slice of T1 axial images were obtained, centered at the navel, with TR 140, 
TE 2.1, flip angle 80, slice thickness 8.0 mm, gap 5.0 mm, FOV 40 x 40, matrix size 512 
x 192, and bandwidth 62.5 kHz. MRI slices were analyzed by MRI software, SliceOmatic 
4.3 (Tomovision, Montreal, CAN). Subcutaneous and visceral adiposity volumes were 
obtained from the umbilical slice, based on a volume of 3D pixels meeting the adipose 
shading threshold within the region of interest. The total abdominal volume was 
computed by summing the calculation for subcutaneous and visceral adiposity volumes. 
 
Analysis of Statistics 
All statistical analyses and data management were performed using Predictive 
Analytics Software Statistics 18.0 (IBM SPSS, Chicago, IL). Subjective characteristics 
were computed as a measure of descriptive statistics and described in terms of a mean, 
standard error of the mean (SEM), and minimum and maximum values of demographic 
variables and body measurements. P-values (p) less than 0.05 were adopted for the 
significance level. 
All of the traditional anthropometrics measurements were assessed twice, and 
coefficients of variation of each value were obtained to examine the intra-observer 
reproducibility of the measurements. Coefficient of variation was also implemented to 
evaluate the reproducibility of SBI over 10 body scans. Total abdominal, subcutaneous 
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and visceral adiposity volumes were quantified from MRI umbilicus scans by two trained 
observers to acquire a coefficient of variation to confirm the reliability of the central 
obesity values. Reproducibility of the traditional anthropometrics, SBI and MRI 
measurements were assessed from a subset of 50 participants. The value of coefficient of 
variation was calculated as the standard deviation of the observations divided by the 
mean of the observations and these values were multiplied by 100 to be expressed as a 
percentage. 
Subjects were assigned randomly into two groups: primary (70%, n=85) and 
validation (30%, n=37). The primary group was used to create prediction equations for 
estimation of central adiposity initially. Then the prediction equations were fit into the 
data derived from the validation group to assess the validity of the equations. 
Pearson's correlation coefficients (r) were used to examine relationships between 
MRI measurements of total abdominal, subcutaneous and visceral fat volumes with 1) 
demographic parameters, 2) anthropometric measurements assessed by traditional manual 
methods, and 3) body measurements measured by SBI. A total of nine measurements 
(sex, waist circumference, waist-to-hip ratio, sagittal diameter, SBI waist circumference, 
SBI hip circumferences, SBI waist-to-hip ratio, central obesity depth, central obesity 
width) that exhibited high correlations with abdominal adiposity were selected to be 
included for the prediction of abdominal adiposity. 
Parameters from three methods were applied to develop prediction equations for 
total abdominal, subcutaneous, and visceral adiposity. These included: 1) traditional 
anthropometric body measurements (waist circumference, waist-to-hip ratio, sagittal 
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diameter) and demographics (sex) as independent variables; 2) SBI parameters (SBI 
waist circumference, SBI hip circumferences, SBI waist-to-hip ratio, central obesity 
depth, and central obesity width) and demographics (sex) as independent variables; and 
3) a combination of traditional anthropometrics, SBI measurements, and demographic 
parameters as independent variables. Sex was dummy coded as women=0 or men=1, and 
ethnicity, as Caucasian=0 or non-White Hispanic=1.  
Prediction models were developed by conducting stepwise multiple linear 
regression analysis. Three different methods for independent predictors were applied with 
dependent variables of abdominal adiposity. Equations that contained the strongest 
predictor variables were selected as the optimal means for predicting total abdominal, 
subcutaneous and visceral fat. Independent variables that exhibited a variance inflation 
factor of 10 or higher in the results were removed to eliminate the impact of collinearity 
among the variables in a regression model. The remaining independent variables were 
included in the resultant stepwise multiple linear regression analysis. 
The final prediction models were applied to the validation group as a means of 
cross-validation. R2 described the percentages explained for the dependent variable for 
prediction equations; these are composed of a combination of independent variables to 
describe how well the model fits the data. The value of R2 (%), mean error (observed 
value – predicted value) and 95% confidence intervals were examined to assess the 
validity of the prediction equations in the validation group.  
 
Results 
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Statistics of Description 
Characteristics of the participants in the primary and validation groups did not 
differ significantly (Table 2.1). In addition to descriptors presented in Table 2.1, the 
mean ± SEM for the primary and validation groups were 0.88 ± 0.01 and 0.87 ± 0.01 for 
waist-to-hip ratio, 0.85 ± 0.01 and 0.84 ± 0.02 for stereovision waist to hip ratio, 0.56 ± 
0.01 and 0.56 ± 0.01 for waist-to-height ratio, 0.54 ± 0.01 and 0.55 ± 0.01 for 
stereovision waist-to-height ratio, and 1.44 ± 0.02 and 1.39 ± 0.41 for stereovision waist 
and thigh ratio. Among the 122 participants, 54.9% (n=67/122) were men and 45.1% 
(n=55/122) women; 65.6% (n=80/122), Caucasian and 34.4% (n=42/122), non-White 
Hispanic. Also, 33.6% (n=41/122) had healthy weights, 32.8% (n=40/122) were 
overweight, or 33.6% (n=41/122) exhibited class I and II obesity.  
 
Reproducibility of Anthropometric, MRI, and SBI Measurements 
All of the coefficients of variation values for traditional anthropometric 
measurements including weight, height, sagittal diameter, and circumferences of arm, 
waist, hip, and thigh were less than 1%, which ensured that the anthropometric variables 
were highly replicable. The reliability of the repeated measurements evaluated by 
coefficients of variation for SBI also exhibited strong agreements for abdominal adiposity 
volumes over 10 repeated body scans. Values of coefficients of variation for 
circumferences of waist, hip, thigh, central obesity depth and width were 0.6, 0.4, 0.6, 
2.4, and 0.9%, respectively.
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Table 2.1. Characteristics of subjects 
Group  
Primary (n=85)  Validation (n=37)  Measurement Method 
Mean ± SEMa Range  Mean ± SEMa Range  p valueb 
Traditional Anthropometric        
Height (cm) 170.38 ± 0.96 148.59 – 189.23  170.04 ± 1.69 147.32 – 189.48  0.85 
Weight (kg) 80.86 ± 1.96 49.80 – 129.64  83.71 ± 2.89 47.36 – 128.05  0.42 
BMI (kg/m2) 27.81 ± 0.60 18.85 – 40.33  28.90 ± 0.85 18.20 – 40.07  0.31 
Waist circumference (cm) 91.92 ± 1.52 67.11 – 127.47  92.96 ± 2.27 65.40 – 115.00  0.71 
Hip circumference (cm) 106.78 ± 1.28 80.50 – 132.08  108.62 ± 1.78 86.00 – 134.00  0.42 
Sagittal diameter (cm) 23.64 ± 0.56 15.80 – 37.00  23.62 ± 0.73 15.40 – 33.00  0.99 
Stereovision Body Imaging         
Stereovision waist (cm)  99.41 ± 1.78 75.00 – 133.08  101.05 ± 2.37 76.43 – 124.48  0.60 
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Table 2.1 (continued)        
Stereovision hip (cm)  107.79 ± 1.21 91.71 – 136.93  110.97 ± 1.83 86.89 – 134.33  0.15 
Stereovision thigh (cm) 64.60 ± 1.06 47.41 – 109.10  67.87 ± 1.97 55.18 – 122.95  0.11 
Central obesity depth (cm)  15.39 ± 0.41 8.91 – 22.79  16.05 ± 3.77 8.83 – 22.08  0.38 
Central obesity width (cm)  34.91 ± 0.58 21.25 – 46.41  35.97 ± 0.81 25.52 – 47.94  0.31 
Magnetic Resonance Imaging        
Abdominal adiposity (cm2)  284.35 ± 16.49 64.23 – 652.63  267.56 ± 22.73 20.64 – 510.43  0.57 
Subcutaneous adiposity (cm2)  218.72 ± 14.05 13.70 – 514.84  201.98 ± 18.23 18.09 – 412.03  0.50 
Visceral adiposity (cm2)  65.63 ± 4.57 7.28 – 187.17  65.58 ± 7.00 2.55 – 188.91  0.99 
a Standard error of mean 
b Significant level by independent samples t-test 
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Two trained observers displayed strong agreement in quantifying abdominal 
adiposity via MRI umbilicus scans. Values of coefficients of variation regarding MRI 
were 0.7, 0.8, and 0.9% for total abdominal, subcutaneous and visceral adiposity, 
respectively.  
 
Correlations between Central Adiposities and Potential Variables  
Pearson correlation coefficients (r) between abdominal adiposity volumes and 
demographics, traditional anthropometrics, and SBI measurements are shown in Table 
2.2. The correlations between total abdominal adiposity and all independent variables 
were statistically significant, except for sex (p=0.10), ethnicity (p=0.10), and height 
(p=0.73). Total abdominal adiposity was highly related to BMI, waist circumference, hip 
circumference, waist-to-height ratio, and sagittal diameter. Relationships between total 
abdominal adiposity and SBI waist circumference, central obesity depth, and SBI waist-
to-height ratio are depicted in Figure 2.2a.  
All variables measured were significantly related to subcutaneous adiposity 
except ethnicity (p=0.08), height (p=0.55), and stereovision waist-to-thigh ratio (p=0.34), 
with age approaching significance (p=0.06) (Table 2.2). Linear relationships between 
subcutaneous adiposity and SBI waist circumference, central obesity depth, and waist-to-
height ratio are illustrated in Figure 2.2b. Subcutaneous adiposity and BMI, waist-to-
height ratio, and SBI hip circumference also were significantly related. 
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Table 2.2. Pearson correlation coefficients between total, subcutaneous, and visceral 
abdominal adiposity volumes, by using demographics, traditional anthropometrics 
and stereovision body imaging parameters  
Abdominal Adiposity Volumea 
Parameters 
Total Subcutaneous Visceral 
 
Demographic 
   
Age 0.29** 0.17 0.50** 
Sex – 0.15 – 0.23** 0.16 
Ethnicity 0.15 0.16 0.05 
 
Traditional Anthropometric 
   
Height (cm) – 0.03 – 0.05 0.05 
Weight (kg) 0.75** 0.73** 0.47** 
Body mass index (kg/m2) 0.85** 0.84** 0.51* 
Waist circumference (cm) 0.85** 0.81** 0.60** 
Hip circumference (cm) 0.83** 0.83** 0.45** 
Waist-to-hip ratio 0.59** 0.50** 0.60** 
Waist-to-height ratio 0.88** 0.84** 0.60** 
Sagittal diameter (cm) 0.84** 0.78** 0.63** 
 
Stereovision Body Imaging     
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Table 2.2 (continued)    
Stereovision waist (cm)  0.79** 0.72** 0.67** 
Stereovision hip (cm)  0.81** 0.84** 0.36** 
Stereovision thigh (cm) 0.54** 0.61** 0.09 
Stereovision waist-to-hip ratio 0.36** 0.22* 0.62** 
Stereovision waist-to-thigh ratio 0.23* 0.09 0.55** 
Stereovision waist-to-height ratio 0.81** 0.74** 0.65** 
Central obesity depth (cm)  0.83** 0.75** 0.71** 
Central obesity width (cm)  0.82** 0.81** 0.47** 
 
a Determined by magnetic resonance imaging 
** Correlation is significant at 0.01 level (2-tailed) 
* Correlation is significant at 0.05 level (2-tailed) 
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For visceral adiposity, all of the correlation coefficients with variables measured 
were also significant, with the exception of sex (p=0.08), ethnicity (p=0.55), height (p= 
0.59), and SBI thigh circumference (p=0.33) (Table 2.2). The highest correlations of 
visceral adiposity were found with central obesity depth (r=0.71), SBI waist 
circumference (r=0.67), and SBI waist-to-height ratio (r=0.65). Of these, central obesity 
depth provided the best correlation to visceral adiposity. Scatter plots of abdominal 
adiposity volumes according to these measurements are shown in Figure 2.2c. 
 
Mathematical Model for Predicting Total Abdominal Adiposity 
The best prediction equation for total abdominal adiposity was obtained by 
traditional anthropometric methods: total abdominal adiposity volume (cm2) = – 470.28 + 
7.10 waist circumference (cm) – 91.01 sex (women=0, men=1) + 5.74 sagittal diameter 
(cm) (Table 2.3). Equations obtained by traditional anthropometric methods resulted in 
the same ultimate model as the combination method due to the fact that the SBI 
parameters were not ideal predictors for predicting total abdominal adiposity. Thus, the 
final model for total abdominal adiposity did not include SBI body measurements. The 
optimal equation for total abdominal adiposity exhibited the highest R2 (89.9%) and 
lowest standard error of the estimate (SEE) (49.18) among ten mathematical models 
(Table 2.3) developed by three different methods; traditional anthropometrics, SBI, and a 
combination. The R2 for this model was not significantly different from the R2 for the 
equation created by the stereovision imaging method (R2 = 84.2%).  
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Figure 2.2. Abdominal adiposity volume determined by magnetic resonance imaging, according to body measurements 
(a) total abdominal, (b) subcutaneous, and (c) visceral adiposity volume according to stereovision body imaging waist 
circumference, central obesity depth, and waist-to-height ratio  
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b. 
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(b) 
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(c) 
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Mathematical Model for Predicting Subcutaneous Adiposity 
The final equation for subcutaneous adiposity was selected from models 
developed by the combination method: subcutaneous adiposity volume (cm2) = – 172.37 
+ 8.57 waist circumference (cm) – 62.65 sex (women=0, men=1) – 450.16 stereovision 
waist-to-hip ratio (Table 2.4). From a total of ten models (Table 2.4), this model 
contained the highest R2 of 90.4%, with the lowest SEE of 40.85. The model developed 
by the stereovision imaging method had a lower R2 of 79.3%, with the highest SEE of 
59.65: subcutaneous adiposity volume (cm2) = – 827.48 + 7.43 stereovision hip 
circumference (cm) + 7.02 central obesity width (cm). Thus, the optimal model for 
subcutaneous adiposity was a combination of demographic (sex), anthropometric (waist 
circumference), and SBI WHR (SBI waist-to-hip ratio) measurements. 
 
 Mathematical Model for Predicting Visceral Adiposity 
The final multiple regression model for the prediction of visceral adiposity was 
best described by the utilization of stereovision and combination methods, which resulted 
in an identical model: visceral adiposity volume (cm2) = – 96.76 + 11.48 central obesity 
depth (cm) – 5.09 central obesity width (cm) + 204.74 stereovision waist-to-hip ratio – 
18.59 sex (women = 0, men = 1) (Table 2.5). The most important influences for 
prediction of visceral adiposity were central obesity depth, central obesity width, 
stereovision waist-to-hip ratio, and sex. The addition of traditional anthropometric 
measurements did not improve the variance, thus the model was identical. Note that with 
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the exception of sex, all variables included in the model were derived from the SBI 
system. Among 11 possible models (Table 2.5), the R2 for the final model (R2=71.7%) 
was significantly higher than the model derived from traditional anthropometric 
measurements (R2=54.2%), and the SEE was only 22.97: visceral adiposity volume (cm2) 
= – 214.28 + 306.03 waist-to-hip ratio + 5.78 sagittal diameter – 1.34 waist circumference 
(cm) (SEE=29.04). 
The prediction equations were then applied to the validation group data and 95% 
confidence intervals were computed in order to check the cross-validity of the developed 
mathematical equations (Tables 2.3, 2.4, 2.5). All of the 95% confidence intervals 
included zero, which implies that the predicted abdominal adiposity (total, subcutaneous, 
and visceral abdominal adiposity) did not differ from the measured values of the 
abdominal adiposity at the level of 0.05. In addition, the mean error (ME) in Tables 2.3, 
2.4, and 2.5 exhibit the differences between the observed values of abdominal adiposity 
measured by MRI and predicted values obtained by the mathematical equations. 
The final prediction equation models for total abdominal, subcutaneous, and visceral 
adiposity are summarized in Table 2.6. All of the predictive models provided large effect 
sizes (larger than 0.35) due to the high R2 values. Consequently, the observed power of 
abdominal adiposity equations among the given sample size ranged from 0.94 to 1. The 
optimal equation for predicting total abdominal adiposity was derived via traditional 
anthropometrics; whereas, subcutaneous and visceral adiposity were obtained by 
combination and stereovision imaging measurement methods, respectively.  
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Table 2.3. Regression coefficients for prediction of total abdominal adiposity by using traditional anthropometric, stereovision 
body imaging and combination measurement methods 
 Independent Variables Measurement 
Method Eq
a 
Intercept Waista Sex SDa CODa sHipa sWaista 
R2 
(%) ME
 (CI)b 
Traditionalc, d 1 – 509.05 – 8.38 – – – – – 80.1 
– 21.09 (–79.56, 
37.37) 
 2  – 492.20   8.78 – 94.04 – – – – 89.2 
– 33.40 (– 91.64, 
24.84) 
  3e – 470.28   7.10 – 91.01 5.74 – – – 89.9 
– 32.04 (– 90.70, 
26.61) 
4 – 237.02 – – – 33.88 – – 72.2 
– 39.32 (– 99.96, 
21.31) 
Stereovision 
Body 
Imagingf 
 5 – 708.42 – – – 19.99 6.36 – 81.8 
– 50.28 (– 112.88, 
12.32) 
 6 – 612.78 – – 36.73 – 22.63 5.29 – 82.9 
– 53.33 (– 116.07, 
9.41) 
  7e – 645.08 – – 61.37 – 12.97 3.79 3.89 84.2 
– 49.36 (– 111.03, 
12.30) 
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Table 2.3 (continued)        
Combinationg 8 – 509.05 – 8.38 – – – – – 80.1 
– 21.09 (– 79.56, 
37.37) 
 9  – 492.20   8.78 – 94.04 – – – – 89.2 
– 33.40 (– 91.64, 
24.84) 
  10e – 470.28   7.10 – 91.01 5.74 – – – 89.9 
– 32.04 (– 90.70, 
26.61) 
 
a Eq, equation; Waist, waist circumference; SD, sagittal diameter; COD, central obesity depth; sHip, stereovision body imaging 
hip circumference; sWaist, stereovision body imaging waist circumference 
b Mean error = observed – predicted (confidence interval) 
c Manual 
d Independent variables include sex, waist circumference, waist-to-hip ratio, sagittal diameter 
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Table 2.4. Regression coefficients for prediction of subcutaneous adiposity by using traditional anthropometric, stereovision 
body imaging and combination measurement methods 
Independent Variables Measurement 
Method 
Eqa 
Intercept Waista Sex WHRa sHipa COWa sWHRa 
R2 
(%) ME (CI)
b 
Traditionalc, d 
1 – 425.91 6.81 – – – – – 72.8 
– 20.22 (– 67.38, 
26.93) 
 2 – 408.19 7.23 – 98.81 – – – – 86.8 
– 33.20 (– 80.70, 
14.30) 
  3e – 204.92 8.82 – 86.07 
 – 
409.19 – – – 88.6 
– 35.86 (– 83.92, 
12.21) 
4 – 877.72 – – – 10.17 – – 76.5 
– 49.07 (– 100.10, 
1.97) 
Stereovision 
Body    
Imagingf 
 5e – 827.48 – – – 7.43 7.02 – 79.3 
– 47.76 (– 99.18, 
3.66) 
Combinationg 
6 – 877.72 – – – 10.17 – – 76.5 
– 49.07 (– 100.10, 
1.97) 
 7 – 769.53 3.37 – – 6.21 – – 82.7 
– 38.15 (– 87.87, 
11.58) 
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Table 2.4 (continued)          
 8 – 566.98 5.59 – 76.30 – 2.80 – – 88.1 
– 38.36 (– 86.96, 
10.24) 
 9 – 96.94 9.21 – 64.91 – – 0.83 – – 504.72 90.5 
– 33.88 (– 81.38, 
13.61) 
 10e – 172.37 8.57 – 62.65 – – – – 450.16 90.4 
– 35.17 (– 83.00, 
12.66) 
 
a Eq, equation; Waist, waist circumference; WHR, waist-to-hip ratio; sHip, stereovision body imaging hip circumference; 
COW, central obesity width; sWHR, stereovision body imaging waist-to-hip ratio  
b Mean error = observed – predicted (confidence interval) 
c Manual 
d Independent variables include sex, waist circumference, waist-to-hip ratio, sagittal diameter 
e Recommended model by stepwise multiple regression analysis 
f Independent variables include sex, stereovision body imaging waist circumference, stereovision body imaging hip 
circumferences, stereovision body imaging waist-to-hip ratio, central obesity depth, central obesity width 
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g Independent variables include sex, waist circumference, waist-to-hip ratio, sagittal diameter, stereovision body imaging waist 
circumference, stereovision body imaging hip circumferences, stereovision body imaging waist-to-hip ratio, central obesity 
depth, central obesity width 
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Table 2.5. Regression coefficients for prediction of visceral adiposity by using traditional anthropometric, stereovision body 
imaging and combination measurement methods 
Independent Variables Measurement 
Method Eq
a 
Intercept WHRa SDa Waista CODa COWa sWHRa Sex 
R2 
(%) ME (CI)b 
1 – 245.98 352.89 – – – – – – 44.4 
2.93 (– 13.04, 
18.89) 
2 – 192.17 211.14 3.02 – – – – – 51.1 
1.77 (– 14.35, 
17.90) 
Traditionalc,d 
 
 
 
  3 e – 214.28 306.03 5.78 – 1.34 – – – – 54.2 
3.29 (– 12.98, 
19.56) 
4 – 57.33 – – – 7.99 – – – 52.3 
– 5.36 (– 22.14, 
11.43) 
5   41.65 – – – 15.62 – 6.20 – – 66.0 
– 3.91 (– 21.63, 
13.80) 
6 – 55.72 – – – 12.23 – 4.84 119.89 – 68.9 
– 1.84 (–19.89, 
16.22) 
Stereovision 
Body 
Imagingf 
 
 
 
 
  7e – 96.76 – – – 11.48 – 5.09 204.74 – 18.59 71.7 
– 2.00 (– 20.36, 
16.37) 
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Table 2.5 (continued)          
8 – 57.33 – – – 7.99 – – – 52.3 
– 5.36 (– 22.14, 
11.43) 
9  41.65 – – – 15.62 – 6.20 – – 66.0 
– 3.91 (– 21.63, 
13.80) 
10 – 55.72 – – – 12.23 – 4.84 119.89 – 68.9 
– 1.84 (–19.89, 
16.22) 
Combinationg 
 
 
 
 
 
  11e – 96.76 – – – 11.48 – 5.09 204.74 – 18.59 71.7 
– 2.00 (– 20.36, 
16.37) 
 
a Eq, equation; WHR, waist-to-hip ratio; SD, sagittal diameter; Waist, waist circumference; COD, central obesity depth; COW, 
central obesity width; sWHR, stereovision body imaging waist-to-hip ratio 
b Mean error = observed – predicted (confidence interval) 
c Manual 
d Independent variables include sex, waist circumference, waist-to-hip ratio, sagittal diameter 
e Recommended model by stepwise multiple regression analysis 
f Independent variables include sex, stereovision body imaging waist circumference, stereovision body imaging hip 
circumferences, stereovision body imaging waist-to-hip ratio, central obesity depth, central obesity width 
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g Independent variables include sex, waist circumference, waist-to-hip ratio, sagittal diameter, stereovision body imaging waist 
circumference, stereovision body imaging hip circumferences, stereovision body imaging waist-to-hip ratio, central obesity 
depth, central obesity width 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
60 
Table 2.6. Final prediction equations for total abdominal, subcutaneous and visceral adiposity volumes by using 
demographic, traditional anthropometric, stereovision body imaging and magnetic resonance imaging measurements 
Adiposity 
Volumea 
Measurement 
Method Predictive Models R
2 (%) 
Traditionalb, c, d  – 470.28 + 7.10 Waist e – 91.01 Sex + 5.74 SDe 89.9 
Stereovisionf – 645.08 + 12.97 CODe + 3.79 sHipe – 61.37 Sex + 3.89 sWaiste 84.2 
Total abdominal 
 
 Combinationg – 470.28 + 7.10 Waiste – 91.01 Sex + 5.74 SDe  89.9 
Traditionalb, c – 204.92 + 8.82 Waiste – 86.07 Sex – 409.19 WHRe 88.6 
Stereovisionf – 827.48 + 7.43 sHipe + 7.02 COWe 79.3 
Subcutaneous 
 
 
 Combination
d, g – 172.37 + 8.57 Waiste – 62.65 Sex – 450.16 sWHRe  90.4 
Traditionalb, c – 214.28 + 306.03 WHR e + 5.78 SD e – 1.34 Waist 54.2 
Stereovisiond, f – 96.76 + 11.48 CODe – 5.09 COW e + 204.74 sWHRe – 18.59 Sex  71.7 
Visceral 
 
 
 Combination
g – 96.76 + 11.48 CODe – 5.09 COWe + 204.74 sWHRe – 18.59 Sex 71.7 
 
a Dependent variable measured by magnetic resonance imaging 
b Manual 
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c Independent variables include sex, waist circumference, waist-to-hip ratio, sagittal diameter 
d Optimal model for predicting central obesity by stepwise multiple regression analysis 
e Waist, waist circumference; SD, sagittal diameter; COD, central obesity depth; sHip, stereovision body imaging hip 
circumference; sWaist, stereovision body imaging waist circumference; WHR, waist-to-hip ratio; COW, central obesity width; 
sWHR, stereovision body imaging waist-to-hip ratio 
f Independent variables include sex, stereovision body imaging waist circumference, stereovision body imaging hip 
circumferences, stereovision body imaging waist-to-hip ratio, central obesity depth, central obesity width 
g Independent variables include sex, waist circumference, waist-to-hip ratio, sagittal diameter, stereovision body imaging waist 
circumference, stereovision body imaging hip circumferences, stereovision body imaging waist-to-hip ratio, central obesity 
depth, central obesity width 
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Discussion 
  The current research is the first to develop mathematical equations for predicting 
abdominal adiposity by utilizing combined parameters derived from demographics, 
traditional anthropometric measurements, and measurements obtained by SBI. The 
results suggest that the body measurements derived from SBI improve the prediction of 
visceral adiposity volume. The R2 in this study for prediction of visceral adiposity 
(71.7%) is lower than that found for both total abdomen (89.9%) and subcutaneous 
(90.4%) adiposity. Clearly, visceral adiposity is more difficult to measure without 
advanced instruments, such as MRI or CT that are stationary and expensive. In this study, 
predictive equations for total abdominal, subcutaneous, and visceral adiposity were 
created using measurements obtained from traditional anthropometrics, SBI parameters, 
and combinations. The most optimal result for the prediction of total abdominal adiposity 
was produced by traditional manual anthropometrics; for subcutaneous adiposity, a 
combination method was better. For visceral adiposity, the method of stereovision body 
imaging yielded the best results. These results were presumably due to the incorporation 
of new parameters of central obesity measured via the SBI system. Central obesity depth 
showed the highest correlation with visceral adiposity, as compared to other body 
measurements (demographics, traditional anthropometrics, and SBI variables). Moreover, 
measurements by SBI alone were not improved by adding traditional manual parameters 
since the SBI measurements were more strongly associated with visceral adiposity. In 
addition, central obesity depth, central obesity width, SBI waist-to-hip ratio and sex 
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appeared to contribute significantly to predict visceral adiposity. 
  Studies have shown that visceral adiposity is related to pathologies that include 
metabolic syndrome (71, 82), insulin resistance (84), and cardiovascular disease (158). 
While subcutaneous adiposity is a better indicator of metabolic syndrome in a specific 
population (159), visceral adiposity may have greater implications in terms of clinical 
health than subcutaneous adiposity (71, 74, 84).  
A study by Goel (2008) developed prediction equations for total abdominal, 
subcutaneous, and visceral adiposity that included traditional anthropometric 
measurements as independent variables and abdominal adiposities, as measured by MRI, 
as a dependent variable (156). These prediction models explained 65%, 67.1% and 52.1% 
of the variances for total abdominal, subcutaneous, visceral adiposity volume, 
respectively. These values were somewhat lower than those obtained in the present 
research (89.9%, 90.4%, and 71.7%) for total abdominal, subcutaneous, and visceral 
adiposity volume. 
Brundavani et al. (2006) also utilized MRI for the assessment of central obesity 
and developed prediction equations for visceral adiposity for men and women (160). The 
final prediction equations for men included weight, waist circumference and BMI as 
independent variables, and weight and waist circumference for women. The R2 for 
visceral adiposity was higher for men (74%) than for women (63%) in the prediction 
equation. These values are similar to the results of the present study, in that the R2 for 
men and women combined was 71.7%, and sex was included as a fourth independent 
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variable in the prediction equation for visceral adiposity. Moreover, sex was included in 
the prediction equations by Goel et al. (2008) (156). Collectively, these results imply that 
sex is a significant factor in order to predict visceral adiposity, as differences exist in fat 
distribution and accumulation between men and women. Previous studies reported that 
women have more subcutaneous adiposity compared to men (26); whereas, men have 
more visceral adiposity as opposed to women (161). 
Janssen et al. (2002) developed prediction equations via multiple regression 
analysis (16). BMI and waist circumference were included as independent variables and 
MRI measured subcutaneous and visceral adiposity as dependent variables. Their model 
described 57% of visceral adiposity for men and 76% for women when BMI was added 
to the model as a first variable, and waist circumferences as a second variable. Waist 
circumference explained 49% of subcutaneous adiposity and 55% of visceral adiposity 
for men, and 52% of subcutaneous adiposity and 76% of visceral adiposity for women. 
The BMI explained 72% of subcutaneous adiposity and 46% of visceral adiposity for 
men and 53% of subcutaneous adiposity and 60% of visceral adiposity for women. These 
results suggest that BMI had a greater influence than waist circumference in describing 
the variance for subcutaneous adiposity; whereas, waist circumference was superior to 
BMI in the prediction of visceral adiposity volume.  
Waist circumference was observed to be the most optimal variable for predicting 
subcutaneous adiposity in the equation model. In contrast to the study conducted by 
Janssen et al. (2002), BMI was not included as a predictor variable in either the 
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subcutaneous or visceral adiposity models (16). In addition, body measurements, such as 
central obesity depth and central obesity width, rather than waist circumference, were 
more precise components for predicting visceral adiposity. These results imply that 
variables derived from stereovision imaging were stronger predictors than waist 
circumference or BMI for predicting visceral adiposity. 
The above mentioned studies utilized MRI for assessment of central obesity; other 
studies examined the use of CT to quantify abdominal adiposity (155, 162). Stanforth et 
al. (2004) compared prediction equations for visceral adiposity by using two different 
methods for men and women (155). A CT technique incorporated subcutaneous 
adiposity, sagittal diameter, age, and ethnicity as independent variables. The traditional 
anthropometric method utilized BMI, waist-to-hip ratio, waist circumference, age and 
ethnicity as independent variables. The R2 for the CT method was 84% for men and 75% 
for women, with a R2 of 78% for men and 73% for women for anthropometrics. These R2 
values are higher than the prediction value of the current study (71.7%), which includes 
both men and women. Since Wajchenberg et al. (2000) denoted that MRI showed lower 
reproducibility for measuring total and visceral adiposity, as opposed to CT (72), this 
suggests that CT may be slightly more precise. But the usage of CT is limited by 
radiation exposure and lack of portability. 
Other prediction equations for visceral adiposity measured by CT were created in 
a Japanese adult population (n=112) (162). This model incorporated sex, age, waist-to-
hip ratio, and internal fat mass (determined by DXA) as independent variables reported a 
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R2 of 74.5%. In addition, a prediction equation for visceral adiposity with the components 
of sex, age, waist-to-hip ratio, and internal fat mass (measured by BIA) resulted in a 
similar R2 of 77.3%. These two models utilizing DXA and BIA measures as independent 
variables produced slightly higher variances than did the measurements by the 
stereovision imaging system (71.7%). 
CT and MRI derived measurements of subcutaneous and visceral adiposity were 
compared in previous studies (163, 164). Total and subcutaneous adiposity were 
overestimated when using CT compared to MRI, but not for visceral adiposity (163). 
Whereas, Seidell et al. have shown that subcutaneous adipose volume measured by CT 
and MRI did not differ statistically, but volume did significantly differ for visceral 
adiposity (164). Collectively, these studies suggest that the prediction equation for 
abdominal adiposity developed by CT-measured and MRI-measured may exhibit a 
disparity due to the error variances in the measurements of abdominal adiposity volumes. 
A variety of 3-D body scanners have been validated for accuracy in measurement 
of waist and hip circumferences against manual tape measurements. Pepper et al. (2010) 
reported that correlations between waist and hip circumferences measured by 3-D laser 
body scanner and by tape were 0.998 and 0.989, respectively (165). Previously, Wells et 
al. (2007) found similar results via a 3-D photonic scanner (Textile and Clothing 
Technology Corporation, [TC]2), with correlation efficients of 0.96 for waist 
circumference and 0.97 for hip circumference (142). Similarly, Zwane et al. (2010) 
observed hip circumference obtained from a 3D photonic scanner ([TC]2) and tape 
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measurement were not statistically in the range of European size of 34 to 44 (157). In 
spite of the accuracy of the body measurements derived from body scanners, these body 
measurements have not been utilized to predict the quantity of abdominal adiposity.  
Postmenopausal women have a higher amount of visceral adiposity, when 
compared to premenopausal women, which indicates that menopausal status or age could 
be a potential variable for predicting abdominal adiposity (166). However, age was 
excluded initially in the data analysis when other independent variables exhibited higher 
correlations with central obesity. The ineffectual correlation between age and abdominal 
adiposity compared to other variables could be explained by a lack of the power to detect 
the significance, since the age distribution among participants was evenly distributed and 
only 5.7% of the participants consisted of women over 50 years old. In addition, 
information on menopausal status was not available for this data set. Future research 
incorporating a higher percentage of elderly women could determine if the age of a 
woman or menopausal status has an impact on prediction of abdominal adiposity. 
Thigh circumference has been suggested to be a significant variable for prediction 
of central obesity because this measure is inversely related to blood glucose, a parameter 
of risk for type 2 diabetes (167). Wells et al. (2008) demonstrated that waist adjusted for 
thigh girth ratio measured by photonic scanner linearly increased across BMI categories 
(143). However, in the prediction equation in the present study, both SBI thigh 
circumference and waist-to-thigh ratio were excluded due to non-significance.  
Waist-to-height ratio (WHtR) also provides a mean for detecting abdominal 
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obesity and related health risks. Ashwell et al. (2011) reported that WHtR was a better 
predictor than waist circumference or BMI, in terms of monitoring cardiometabolic risk 
(90). Parikh et al. (2007) confirmed that WHtR serves as an index of central obesity and 
it was more effective in defining metabolic syndrome than waist circumference (168).  
In this study, traditional and stereovision waist-to-height ratio exhibited high 
correlations with total abdominal, subcutaneous, and visceral adiposity. However, the 
former were excluded in the prediction model because other independent variables had 
stronger correlations with abdominal adiposity volumes. In addition, multicollinearity 
existed between independent variables that influenced the waist-to-height ratio, resulting 
in an exclusion from the prediction model. For example, in the creation of the visceral 
adiposity prediction model, waist-to-height ratio had a high correlation with central 
obesity depth (r=0.89, p<0.001). Yet, a substantial amount of visceral adiposity is 
explained by central obesity depth; thus, the waist-to-height ratio, which explains a 
similar portion of visceral adiposity, was excluded in the model. Then other variables 
were examined by the process of stepwise multiple regression analysis in order to 
ascertain whether they should be included in the model. For the total abdominal and 
subcutaneous models, waist-to-height ratio was excluded again, despite having the 
highest correlation with the adiposity volumes, because of the removal test in the 
stepwise multiple regression analysis. In this test, the least useful independent variable is 
removed from the equation when each variable is included in the equation. 
The current research observed that body ratios (including waist-to-height ratio and 
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waist-to-thigh ratio) were not significant factors in the prediction of visceral adiposity, 
except for waist-to-hip ratio. The waist-to-hip ratio obtained via SBI was the third 
strongest predictor in the equation for subcutaneous and visceral adiposity. However, 
central obesity depth and central obesity width as measured by SBI were superior 
predictors for visceral adiposity, as compared to SBI waist-to-hip ratio.  
In summary, the prediction equations for abdominal adiposity volumes were 
compared using traditional anthropometrics, SBI or a combination of both. For total and 
subcutaneous adiposity, traditional methods were just as effective as for SBI. However, 
for visceral adiposity, the most critical measure for assessing health risk, SBI provided a 
more optimal prediction model. Since the SBI system is inexpensive and non-invasive, it 
has potential for assessment of visceral adiposity in a field setting where CT or DXA are 
not available.  
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CHAPTER 3: EFFICACY OF THIGH VOLUME RATIOS ASSESSED VIA 
STEREOVISION BODY IMAGING AS A PREDICTOR OF VISCERAL 
ADIPOSITY MEASURED BY MAGNETIC RESONANCE IMAGING 
Abstract 
Central obesity, especially excessive accumulation of visceral adiposity, is a 
public health concern because it is associated with cardiovascular disease and type 2 
diabetes. Assessment of this type of obesity via regional body volumes or proportions 
may be more crucial than overall adiposity, in terms of the clinical consequences. The 
purpose of this research was to explore the efficacy of regional volumes of thigh ratios 
assessed by stereovision body imaging (SBI) as a predictor of visceral adiposity, as 
measured by magnetic resonance imaging. Body measurements obtained via SBI also 
were utilized to explore the disparities of body size and shape in men and women and the 
risks associated with accumulation of visceral adiposity. A total of 121 adults were 
measured for total and regional body volumes, as well as volume ratios. Irrespective of 
body bass index (BMI) classification, men exhibited greater total body (80.95 L vs. 72.41 
L), torso (39.26 L vs. 34.13 L), and abdomen-hip (29.01 L vs. 25.85 L) volumes, and 
waist circumference (95.21 cm vs. 88.46 cm) than women. Women had higher thigh 
volumes (4.93 L vs. 3.99 L), hip circumference (112.56 cm vs. 106.68 cm), and lower 
body-volume ratios [thigh to total body (0.07 vs. 0.05), thigh to torso (0.15 vs. 0.11), and 
thigh to abdomen-hip (0.20 vs. 0.15); p<0.05]. Thigh volume in relation to torso [odds 
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ratios (OR) 0.44] and abdomen-hip (OR 0.41) volumes were negatively associated with 
increased risks of a greater visceral adiposity deposition, even after controlling for age, 
sex, and BMI (p<0.05). The three-dimensional (3D) SBI provided an excellent method 
for determining body size and shape in men and women, and confirmed that women are 
more prone to exhibit a gynoid body shape as shown by greater lower-body volume 
ratios. In contrast, men are more likely to exhibit an android body type. The unique 
parameters of the volume of thigh, in relation to torso and abdomen-hip volumes, by SBI 
was highly effective in predicting visceral adiposity.  
 
Introduction 
Obesity is a significant public health concern associated with hypertension, 
dyslipidemia, coronary heart disease, and type 2 diabetes (1-4). In the United States, 
approximately one-third of the population is overweight (33.3%) and one-third is obese 
(34.9%) (8). At present, body mass index (BMI) is the most commonly used technique to 
assess obesity in populations due to its simplicity. Yet, this method is crude, in that body 
weight and height only estimate overall obesity, without consideration of the distribution 
of body fat (169). 
Generally, fat depots are classified as visceral and subcutaneous adiposity (74). 
Within the abdominal area, visceral adiposity is the more metabolically active depot due 
to its associations with escalated risks of cardiovascular disease, diabetes, and metabolic 
syndrome; whereas, subcutaneous adiposity is linked with lower health risks (71, 74, 82, 
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84, 170). Since visceral adiposity is more of a primary concern than is subcutaneous, this 
research explored the relationships between visceral adiposity determined by magnetic 
resonance imaging (MRI) and body volume measurements estimated by three-
dimensional (3D) stereovision body imaging (SBI).  
Lower body factors (thigh circumference, thigh fat, leg fat, leg to trunk fat ratio, 
sagittal abdominal diameter to thigh circumference ratio) have been shown previously to 
have favorable effects on normal insulin and glucose levels (118-121), metabolic 
dysfunction (122-124), and risks of cardiovascular disease (123, 125, 126). Higher values 
of lower body factors have been suggested to exhibit protective effects on health risks 
associated with obesity-related diseases (121, 123, 124). It is predicted that lower body 
components, such as thigh volume in relation to total body, trunk, or abdomen-hip would 
be linked negatively with the accumulation of visceral adiposity. 
To date, instruments that measure regional adiposity, such as dual-energy x-ray 
absorptiometry (DXA), computed tomography (CT), and MRI, are restricted in field 
settings due to their bulkiness, cost, and/or radiation exposure. An innovation of this 
research is the use of a 3D SBI system to collect body measurements in a rapid and 
inexpensive manner. This device provides a visual presentation of human body shape and 
size, including volumes of total body, torso (neck to umbilicus), abdomen-hip (umbilicus 
to crotch) and thigh (crotch to top of knee) (Figure 3.1). Previously, body volume 
measured via this system showed strong agreement with air displacement 
plethysmography (ADP) (R2>0.99, p<0.01). No significant differences were found 
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between these methods (mean difference -0.17, p>0.05), indicating the preciseness of this 
technique (138). Also, measurements were highly reproducible, with intraclass 
correlation coefficient and coefficient of variation values lower than 0.99 and 1.9, 
respectively (138). In the present research, unique body volume measurements derived 
via SBI were utilized to assess the association with visceral adiposity.  
Stereotypically, men accumulate more fat in the abdominal region, which is 
characterized by an android or apple shape; whereas, women have greater fat depots in 
the gluteal-femoral area, and exhibit a gynoid or pear-shaped body type (115, 171). Thus, 
men and women were assessed by SBI to document precise disparities in their body size 
and shape. Because central fat depots increase with age, especially for women with 
postmenopausal status (166, 172-174), demographics were taken into account for the 
examination of possible relationships between body volume measurements and obesity 
measures. 
 
Method and Procedures 
Design of Study 
A total of 121 Caucasian and non-White Hispanic men (n=67) and women (n=54) 
made two visits to the The University of Texas at Austin SBI laboratory and the MRI 
Imaging Research Center. Subjects were instructed to fast for 4 hours prior to the visit 
and avoid excessive perspiration, heavy exercise, and caffeine or alcohol for 10 hours.  
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Demographic and health history questionnaires were administered at visit 1. Participants 
were measured for body size and shape by anthropometrics, including height, weight by a 
scale and a stadiometer; body circumferences (arm, waist, hip, thigh) by SBI; and total 
percent body fat by ADP within 3 hours. Ten body imaging scans of 200 
milliseconds each were performed via SBI to assess body composition, such as body 
circumferences, total, and regional body volumes. At visit 2, MRI scans of the abdominal 
area were obtained for central obesity assessment within 5 days of the anthropometric 
measurements.  
 
Subjects  
Healthy Caucasian and non-White Hispanic men and women, aged 18 to 65 years 
with a BMI range of 18.5 to 40 kg/m2 were recruited via notices posted online and on 
bulletin boards, and through word-of-mouth. Prescreening over the phone was performed 
before the first study visit. Criteria for exclusions were metallic/electronic implants or 
heavy metal ink tattoos, having known diseases, or being pregnant or breastfeeding. The 
risks and benefits of the study were explained and informed consents were obtained. The 
University of Texas at Austin Institutional Review Board approved this study. 
 
Anthropometrics 
Participants were measured for weight and height, wearing light clothing and 
barefoot, by an electronic scale (Tanita, Arlington, IL) to the nearest 0.1 kg and a 
 
 
 
 
 
 
   
 
75 
Figure 3.1. Total and regional body volumes according to BMI classification assessed by 
a stereovision body imaging system. Left to right: front of total body volume, back of 
total body volume, front of torso and thigh volums, front of abdomen-hip and thigh 
volumes, and back of abdomen-hip and thigh volumes.  
(a) Men, BMI 20.2 kg/m2, healthy weight 
 
 
(b) Men, BMI 25.6 kg/m2, Overweight 
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(c) Men, BMI 30.8 kg/m2, obese class I 
 
 
 (d) Men, BMI 40.3 kg/m2, obese class II 
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(e) Women, BMI 18.9 kg/m2, healthy weight 
 
 
(f) Women, BMI 25.2 kg/m2, overweight 
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(e) Women, BMI 30.0 kg/m2, obese class I 
 
 
(f) Women, BMI 40.1 kg/m2, obese class II
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stadiometer (Health o meter, South Shelton, CT) to the nearest 0.1 cm, respectively. BMI 
was calculated as weight in kg divided by height in m2 and classified as healthy weight  
(18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), obese class I (30-34.9 kg/m2), or obese 
class II (35-40 kg/m2). A MyoTape body tape (AccuFitness, Greenwood Village, CO) 
measured body circumferences (arm, waist, hip, and thigh). Anthropometric assessments 
followed standard protocols for anthropometric measurements (175).  
 
System of Stereovision Body Imaging 
 A 3D SBI measured body size and shape of the participants (138, 149). Subjects 
were instructed to wear minimal tight underwear and a swimming cap during the 
assessment. A blindfold was provided to protect the subjects’ eyes from the bright light 
emanating from the projectors. During acquisition, participants posed with their legs 
slightly spread and arms extended from the torso while holding their breath for one 
second. A total of ten body scans of 200 milliseconds each was completed for the 
subjects. Detailed information regarding the instrument was previously reported by Xu et 
al. (2009) (138) and Lee et al. (2014) (149).  
 Body volume measurements assessed via SBI included total body, torso (neck to 
crotch), abdomen-hip (smallest point of waist to crotch) and thigh (crotch to mid-thigh). 
Figure 3.1 shows the body image and regional body volumes assessed by SBI according 
to BMI classification. Subsequently, body volume ratios that reflect upper (torso/total 
body, abdomen-hip/total body, abdomen-hip/torso) and lower body volume ratios  
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(thigh/total body, thigh/torso, thigh/abdomen-hip) were computed. Body circumferences 
including shoulder, chest, abdomen, waist, hip, crotch, upper thigh, lower thigh, knee, 
and calf were assessed as well. A stereovision body imaging waist-to-hip ratio 
measurement was computed by waist circumferences (cm) divided by hip circumferences 
(cm). 
 
Magnetic Resonance Imaging  
The evaluation of abdominal adiposity volumes was performed using FDA-
approved pulse sequences via a MRI 3.0 T General Electric scanner (GE Healthcare, 
Milwaukee, WI) by a certified MR technician. A 3-plane localizer scan was performed 
while centering the iliac crest after the subject was positioned on the magnet. A coronal 
slice was obtained as TR 140, TE 2.1, flip angle 80°, slice thickness 8.0 mm with gap 5.0 
mm, FOV 40 x 40, matrix 512 x 93, and bandwidth 62.5 kHz, while centering at the 
navel. The coronal slice was analyzed for assessment of subcutaneous and visceral 
adiposity volume via SliceOmatic 4.3 (Tomovision, Montreal, CAN). Total abdominal 
adiposity was computed by adding the volumes of subcutaneous and visceral adiposity. 
Operation of the MRI scanner and maintenance of all the safety elements were performed 
only by imaging research center approved personnel.  
 
Air Displacement Plethysmography  
 Percent fat mass and fat-free mass were calculated from body mass, density, and 
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volume, as determined by a BOD POD® body composition tracking system (Life 
Measurement System, Concord, CA). Participants were instructed to wear minimum 
clothing and cover their hair with a swimming cap to reduce error variance. Weights were 
measured by electronic scale and subjects were seated inside the sealed chamber. Under 
the isothermal conditions, body density was estimated via variations in pressure and body 
volume. The breathing circuit system measured thoracic gas volume while subjects 
breathed normally. Five prediction equations (Siri, Schtte, Ortiz, Brozek, Lohman) were 
available in the BOD POD® software in order to accurately measure body fat percentage 
for different populations, including the general population (44), African American males 
(47), African American females (46), lean and obese individuals (56) and children aged 
under 17 years old (45). These prediction equations were based on measurements of body 
volume and body mass to estimate fat and fat-free mass.  
 
Analysis of Statistics 
Statistical analyses were performed independently in men and women due to the 
sex differences in total and regional fat distribution. The normality of the distributions of 
the variables was examined by the Kolmogorov-Smimov test (176). Overall 
characteristics of the participants were described as mean and standard error of the mean. 
A one-way analysis of variance (ANOVA) was used to detect mean differences between 
different sex and BMI groups for demographic parameters and body measurements 
assessed via traditional anthropometrics, SBI, MRI, and ADP. When the results of 
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ANOVA were significant, pairwise comparisons detected where the differences might 
fall by post hoc analysis of Bonferroni correction. A univariate general linear model 
analysis also was conducted to explore disparities of total/regional body volumes and 
body volume ratio parameters among different sex and BMI groups. Line graphs were 
created to visually examine the associations between body volume parameters and BMI 
classification (healthy weight, overweight, obese class I and II).  
 Age-adjusted partial Pearson's correlation coefficients were used to describe the 
relationships between total/regional body volumes (torso, abdomen-hip, thigh) and 
upper/lower volume ratios with a) overall obesity measures (BMI, percent body fat); and 
b) central obesity parameters (subcutaneous and visceral adiposity). Scatter plots 
depicting the R2 line of best fit were created to investigate linear associations between 
body fat percentage measured by ADP and total/regional body volumes determined via 
SBI, as well as visceral abdominal adiposity volume assessed by MRI and body volume 
ratios acquired by SBI, according to BMI classification.   
The odds ratios (OR) were computed via multinomial logistic regression analysis 
to predict of the risks of being in the low tertile of visceral fat volume versus middle or 
high, with one standard deviation increases in total/regional body volume parameters. 
Analyses were preceded with unadjusted (model 1); adjusted for age and sex (model 2); 
and adjusted for age, sex, and BMI group (model 3) models in order to accurately explore 
risks involved while taking age, sex, and BMI into account. Total and regional body 
volume parameters were converted into Z-scores to compare the study results. The Z-
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score was computed by subtracting the group mean value from the individual’s observed 
value, and then dividing these subtracted values by the group sample standard deviation.   
The level of significance adopted were p<0.05. All statistical analyses were 
performed by using Predictive Analytics Software Statistics 18.0 (IBM SPSS, Chicago, 
IL). 
 
Results 
Description of Statistics and line Graphs of Body Volumes According to BMI Groups 
The general characteristics and body measurements of the subjects are shown in 
Table 3.1. The mean age, weight, height, and BMI of the overall subjects were 34.4 
years, 81.6 kg, 170.3 cm, and 28.0 kg/m2, respectively. Among the 121 participants, 
35.5% had a healthy weight (n=24, men; n=19, women), 30.6% were overweight (n=23, 
men; n=14, women), 22.3% exhibited class I obesity (n=14, men; n=13, women), and 
11.6% showed class II obesity (n=6, men; n=8, women). The BMI values for men and 
women in each BMI category did not differ as the group values were 22.3 kg/m2 and 22.4 
kg/m2 in healthy, 27.7 kg/m2 and 27.9 kg/m2 in overweight, 32.7 kg/m2 and 32.8 kg/m2 in 
obese class I, and 37.2 kg/m2 and 36.8 kg/m2 in obese class II for men and women, 
respectively (p>0.05). In addition, 65% were Caucasian and 35% were non-White 
Hispanic. All parameters listed in Table 3.1 were significantly different between men and 
women, except for age, BMI, and abdomen-hip to total body volume ratio, total 
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abdominal adiposity. Abdomen-hip volume (p=0.06), torso to total body volume ratio 
(p=0.07), and visceral adiposity (p=0.08) closely approached significance (Table 3.1). 
In comparison to men, women possessed greater total abdominal and 
subcutaneous fat and less visceral fat, as determined by MRI. Yet only the difference in 
subcutaneous adiposity was statistically significant, with the higher visceral fat in men 
approaching significance (p=0.08). Moreover, a significantly higher percentage of total 
body fat, as assessed by ADP was observed in women, as opposed to men (p<0.05) 
(Table 3.1). 
Regardless of the BMI classification, men exhibited greater total body, torso 
volumes, and waist circumference than women, while greater abdomen-hip volume 
(p=0.06) approached significance. Women had higher thigh volumes, hip circumference, 
and body volume ratio than men, including thigh to total body, thigh to torso, and thigh to 
abdomen-hip (Table 3.1). 
Differences between total and regional body volumes and volume ratios in men 
and women are illustrated in Figure 3.2, according to BMI classification. Total and 
regional body volumes increased, with the exception of thigh volume, in correspondence 
with increasing BMI classification regardless of sex (Figure 3.2a). Thigh volume was 
statistically greater for the obese class II group, in comparison to healthy, overweight and 
obese class I groups, but not between overweight and obese class II groups (Figure 3.2a).  
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Table 3.1. Subject characteristics and body measurements by sex 
Sex  
Men (n=67)  Women (n=54)  Parameters 
Mean ± SEMa Range  Mean ± SEMa Range p valueb 
Demographics        
Age (years) 34.37 ± 1.42 18.6 – 59.8  34.39 ± 1.31 18.5 – 60.6  1.00 
Ethnicity (%Caucasian/Hispanic) 65.7/34.3 –  64.8/35.2 –  – 
Traditional Anthropometrics        
Height (cm) 175.78 ± 0.87 161.29 – 189.48  163.59 ± 0.95 147.32 – 178.82  0.00 
Weight (kg) 86.26 ± 2.17 59.51 – 129.64  75.89 ± 2.25 47.36 – 126.69  0.00 
BMI (kg/m2) 27.68 ± 0.63 19.10 – 40.30  28.45 ± 0.76 18.61– 40.07  0.43 
Stereovision Body Imaging         
Stereovision waist (cm)  95.21 ± 1.63 73.26 – 127.47  88.46 ± 1.89 65.40 – 115.00  0.01 
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Table 3.1 (continued)        
Stereovision hip (cm)  106.68 ± 1.17 92.17– 132.36  112.56 ± 1.80 87.19 – 151.07  0.01 
Waist-to-hip ratio 0.89 ± 0.01 0.74 – 1.09  0.79 ± 0.01 0.68 – 0.96  0.00 
Volume (L):        
Total body  80.95 ± 2.19 54.66 – 122.89  72.41 ± 2.34 43.91 – 123.91  0.01 
Torso  39.26 ± 1.37 23.59 – 67.70  34.13 ± 1.42 17.90 – 54.50  0.01 
Abdomen-hip  29.01 ± 1.19 15.91 – 59.39  25.85 ± 1.16 12.14 – 45.31  0.06 
Thigh  3.99 ± 0.15 2.24 – 9.01  4.93 ± 1.17 3.14 – 10.52  0.00 
Volume Ratio:        
Torso to total body  0.48 ± 0.00 0.39 – 0.58  0.46 ± 0.01 0.35 – 0.59  0.07 
Abdomen-hip to total 
body  
0.35 ± 0.01 0.27 – 0.48  0.35 ± 0.01 0.27 – 0.45  0.90 
Abdomen-hip to torso  0.73 ± 0.01 0.61 – 0.89  0.75 ± 0.01 0.65 – 0.88  0.04 
 
 
 
 
 
 
   
 
87 
Table 3.1 (continued)        
Thigh to total body  0.05 ± 0.00 0.03 – 0.07  0.07 ± 0.00 0.05 – 0.10  0.00 
Thigh to torso  0.11 ± 0.00 0.05 – 0.17  0.15 ± 0.01 0.08 – 0.27  0.00 
Thigh to abdomen-hip  0.15 ± 0.01 0.06 – 0.24  0.20 ± 0.01 0.11 – 0.33  0.00 
Magnetic Resonance Imaging        
Total abdominal adiposity (cm2)  259.15 ± 18.54 20.64 – 652.63  300.56 ± 18.94 56.81 – 544.98  0.12 
Subcutaneous adiposity (cm2)  187.50 ± 15.41 13.70 – 514.84  242.62 ± 15.46 35.82 – 458.81  0.01 
Visceral adiposity (cm2)  71.65 ± 5.85 2.55 – 188.91  57.94 ± 4.48 8.12 – 137.78  0.08 
Air Displacement Plethysmography        
Total body fat (%) 26.00 ± 1.20 9.00 – 49.70  37.18 ± 1.35  16.10 – 53.70  0.00 
 
a Standard error of mean 
b Significant level determined by one-way analysis of variance (ANOVA) 
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Lower-body volume ratios (thigh to total body, thigh to torso, thigh to abdomen-
hip) decreased according to BMI groups, specifically from healthy weight to obese class I 
participants (Figure 3.2b). No significant differences were observed between obese class 
I and II participants for lower body volume ratios (thigh to total body, thigh to torso, and 
thigh to abdomen-hip) (Figure 3.2b). 
  
Scatter plots of volumes according to overall and central obesity measures  
Figure 3.3 presents scatter plots of total/regional body volumes (torso, abdomen-
hip, and thigh) assessed by SBI and percent body fat measured by ADP in men and 
women, according to BMI classifications. Total body, torso, and abdomen-hip volumes 
were positively correlated with percent body fat and these relationships correspond with 
increasing BMI classification. Thigh volume also showed positive relationships with 
percent body fat (Figure 3.3g,h); however, the correlation coefficients were lower but 
still significant then that observed for values of other regional body volumes (Figure 
3.3a-f). The scatter plots of visceral adiposity assessed by MRI and lower-body volume 
ratios (thigh to torso and thigh to abdomen-hip) measured by SBI, according to BMI 
classifications are illustrated in Figure 3.4. These lower-body volume ratios also showed 
negative associations with visceral adiposity and these relationships were more reliable in 
women. While in men, the scatter plots exhibited greater variations and did not show 
strong correspondence with BMI groups (Figure 3.4). 
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Figure 3.2. Total and regional body volumes and body volume ratios of men and women 
assessed by stereovision body imaging, according to BMI classification 
(a) Total and regional body volumes  
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(b) Regional body volume ratios 
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Figure 3.3. Scatter plots of total/regional body volumes assessed by stereovision body 
imaging and percent body fat, as measured by air displacement plethysmography in men 
and women, according to BMI classifications 
(a) Total body volume according to % body fat in men  
(b) Total body volume according to % body fat in women  
(c) Torso volume according to % body fat in men  
(d) Torso volume according to % body fat in women  
(e) Abdomen-hip volume according to % body fat in men 
(f) Abdomen-hip volume according to % body fat in women  
(g) Thigh volume according to % body fat in men 
(h) Thigh volume according to % body fat in women 
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Correlations between Body Volumes and Obesity Measures 
Age-adjusted partial Pearson correlation coefficients for overall/central obesity 
measures with whole/regional body volumes and body volume ratios are presented in 
Table 3.2. Total and regional body volumes (torso, abdomen-hip) derived from SBI were 
closely related with overall obesity measures (BMI and percent body fat) and 
subcutaneous adiposity volumes. A significant, but weaker relationship has, observed 
with visceral fat (p<0.01). In contrast, thigh volume was not related to visceral adipose 
tissue.  
In men and women, the largest negative correlations for visceral adiposity were 
observed with thigh to abdomen-hip volume ratio, clearly followed by thigh to torso 
volume ratio. Only women showed a significant negative relationship with thigh to total 
body volume ratio and visceral adiposity (Table 3.2). In addition, upper body volume 
ratios, such as torso to total body volume ratio, abdomen-hip to total body volume ratio, 
and abdomen-hip to torso volume ratio, were positively correlated with these obesity 
measures (Table 3.2).  
 
Odds Ratios for Visceral Fat Tertile, Total/Regional Body Volumes and Volume Ratios 
 Multinomial logistic regression analysis was conducted to predict tertiles of visceral 
abdominal fat depots assessed via MRI, according to total/regional body volumes and 
volume ratios measured by SBI. The odds ratios and 95% confidence intervals by one 
standard deviation increase of each parameter value for increase in visceral abdominal 
 
 
 
 
 
 
   
 
97 
Figure 3.4. Scatter plots of visceral adiposity assessed by magnetic resonance imaging 
according to lower-body volume ratios, as measured by stereovision body imaging in 
men and women, according to BMI classifications. 
(a) Visceral adiposity according to thigh to torso volume ratio in men  
(b) Visceral adiposity according to thigh to torso volume ratio in women 
(c) Visceral adiposity according to thigh to abdomen-hip volume ratio in men  
(d) Visceral adiposity according to thigh to abdomen-hip volume ratio in women 
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Table 3.2. Age-adjusted partial Pearson correlation coefficients between overall/central obesity measures and total/regional 
body volumes and body volume ratios, as assessed by air displacement plethysmography, magnetic resonance imaging and 
stereovision body imaging  
Overall Obesity Measure  Abdominal Adiposity Volumed 
Parametersa 
BMIb % Body Fatc  Subcutaneous Visceral 
 
Men      
 
Volume:      
Total body 0.90** 0.82**  0.85** 0.39** 
Torso 0.92** 0.85**  0.87** 0.40** 
Abdomen-hip 0.89** 0.85**  0.88** 0.36** 
Thigh 0.47** 0.46**  0.51** 0.20 
Volume Ratio:      
Torso to total body 0.74** 0.70**  0.69** 0.36** 
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Table 3.2 (continued)      
Abdomen-hip to total body  0.73** 0.77**  0.75** 0.28* 
Abdomen-hip to torso  0.38* 0.49**  0.45** 0.09 
Thigh to total body  – 0.30* – 0.24  – 0.19 – 0.18 
Thigh to torso  – 0.45** – 0.39*  – 0.35** – 0.26* 
Thigh to abdomen-hip  –0.55** – 0.52**  – 0.46** – 0.29* 
Women      
 
Volume:      
Total body  0.90** 0.87**  0.85** 0.55** 
Torso  0.92** 0.90**  0.88** 0.64** 
Abdomen-hip  0.92** 0.88**  0.89** 0.63** 
Thigh  0.52** 0.54**  0.48** 0.09 
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Table 3.2 (continued)      
Volume Ratio:      
Torso to total body  0.67** 0.70**  0.68** 0.65** 
Abdomen-hip to total body  0.74** 0.69**  0.73** 0.67** 
Abdomen-hip to torso  0.25 0.14  0.23 0.14 
Thigh to total body  – 5.12** – 0.46**  – 0.49** – 0.64** 
Thigh to torso  – 0.61** – 0.60**  – 0.61** – 0.67** 
Thigh to abdomen-hip  – 0.70** – 0.65**  – 0.68** – 0.71** 
 
a Determined by SBI 
b Determined by weight in kg divided by height in m2  
c Determined by ADP 
d Determined by MRI 
* Correlation is significant at 0.05 level (2-tailed) 
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** Correlation is significant at 0.01 level (2-tailed) 
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adiposity tertile are demonstrated in Table 3.3. Model 1 was unadjusted, model 2 was 
adjusted for age and sex, and model 3 was adjusted for age, sex, and BMI. Regardless of 
the adjustment for age and sex (model 1 and 2), higher total and regional body volumes 
(total body, torso, abdomen-hip), as well as upper body volume ratios (torso to total body, 
abdomen-hip to total body), were associated with being in a higher visceral adiposity 
tertile compared to lowest tertile (p<0.01).  
 After adjustment for age and sex (model 2), torso volume and abdomen-hip volume 
were the strongest variables associated with increased risk for visceral adiposity. Among 
the body volume ratio parameters, the greatest decrease in the risks of having visceral 
adiposity was found with thigh to abdomen-hip volume and thigh to torso volume 
(p<0.01) (Table 3.3).  
 However, when the model was adjusted for age, sex, and BMI group (model 3), 
these associations with visceral adiposity were not significant (p>0.05). The exceptions 
were for thigh to torso and thigh to abdomen-hip volume ratios, with the odds ratios for 
the highest tertile compared with lowest visceral adiposity tertiles being 0.44 and 0.41, 
respectively (p<0.05) (Table 3.3). 
 
Discussion 
 The inverse relationships of abdominal visceral adiposity with lower body volume 
ratios reported in this study suggest that greater volumes in the lower body are more 
metabolically favorable than those in the upper regions. In addition, decreased visceral  
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Table 3.3. Logistic regression analysis to predict tertiles of visceral abdominal fat depots measured by magnetic resonance 
imaging, according to whole/regional body volume and volume ratios assessed by stereovision body imagining  
  Tertile of Visceral Fatb   
Model 1c  Model 2c  Model 3c Parametersa 
Low vs. 
Middle 
Low vs. High  Low vs. 
Middle 
Low vs. High  Low vs. 
Middle 
Low vs. High 
Volume       
Total body 3.58** 
(1.80 – 7.12) 
6.98** 
(3.30 – 14.74) 
3.39** 
(1.65 – 6.94) 
3.08**  
(3.08 – 15.57) 
1.89 
(0.63 – 5.63) 
2.72 
(0.82 – 9.03) 
Torso  4.36**  
(2.10 – 9.08) 
8.76**  
(3.95 – 19.47) 
 
3.87** 
(1.83 – 8.21) 
7.75** 
(3.34 – 17.96) 
 
2.70 
(0.79 – 9.24) 
3.62 
(0.95 – 13.89) 
Abdomen-
hip  
4.93**  
(2.25 – 10.80) 
9.21**  
(3.98 – 21.31) 
 4.07** 
(1.85 – 8.94) 
7.50** 
(3.17 – 17.74) 
 2.55 
(0.74 – 8.75) 
2.88 
(0.76 – 10.85) 
Thigh  1.25  
(0.77 – 2.03) 
1.44  
(0.89 – 2.32) 
 1.63  
(0.92 – 2.90) 
2.17* 
(1.17 – 4.03) 
 0.95  
(0.48 – 1.88) 
1.02 
(0.49 – 2.13) 
 
 
 
 
 
 
   
 
106 
Table 3.3 (continued)        
Volume Ratio         
Torso to total 
body  
3.49** 
(1.84 – 6.60) 
6.76** 
(3.30 – 13.88) 
 2.99** 
(1.56 – 5.73) 
5.33** 
(2.51 – 11.29) 
 1.85 
(0.81 – 4.22) 
1.99  
(0.76 – 5.25) 
Abdomen-
hip to total 
body  
3.64**  
(1.87 – 7.09) 
6.09** 
(2.98 – 12.44) 
 3.06** 
(1.56 – 6.01) 
4.65** 
(2.23 – 9.70) 
 1.72 
(0.71 – 4.17) 
1.54 
(0.58 – 4.09) 
Thigh to 
total body  
0.46** 
(0.27 – 0.77) 
0.23** 
(0.13 – 0.42) 
 0.52* 
(0.29 – 0.91) 
0.31** 
(0.16 – 0.60) 
 0.64  
(0.34 – 1.18) 
0.51 
(0.24 – 1.06) 
Thigh to 
torso  
0.37**  
(0.21 – 0.64) 
0.17** 
(0.08 – 0.33) 
 0.42** 
(0.23 – 0.75) 
0.22** 
(0.11 – 0.46) 
 0.56 
(0.29 – 1.07) 
0.44* 
(0.19 – 0.99) 
Thigh to 
abdomen-hip  
0.33** 
(0.18 – 0.59) 
0.14**  
(0.07 – 0.29) 
 0.37** 
(0.20 – 0.68) 
0.19** 
(0.09 – 0.40) 
 0.54 
(0.27 – 1.08) 
0.41* 
(0.17 – 0.99) 
 
Data on exponential ß and 95 % confidence intervals are shown. 
a Determined by SBI 
b Determined by MRI   
c Model 1, unadjusted; model 2, adjusted for age, sex; model 3, adjusted for age, sex, BMI group 
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* Correlation is significant at 0.05 level (2-tailed) 
** Correlation is significant at 0.01 level (2-tailed)
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adiposity was observed with a high thigh volume in relation to abdomen-hip and torso 
volumes, independent of age, sex, and BMI groups. Thus, this type of fat distribution in 
the lower body appears to be metabolically advantageous for both men and women.  
 Positive effects of the lower body regions on obesity-related health risk factors have 
been reported previously (119, 177-179). It is plausible that the accumulation of fat in 
peripheral regions of the body such as thighs, or legs, may restrict the ectopic fat 
accumulation in the upper body torso, which are more closely linked with metabolic risks 
(180). Differences in the response rate and introduction of catecholamine-induced 
lipolysis between gluteal and abdominal fat deposits may explain these adverse effects 
from a physiological view (181). The reported favorable impact of lower body factors on 
metabolic health may be related to the adverse effect of inflammatory cytokines on 
accumulation in abdominal adiposity. In contrast, peripheral adiposity is negatively 
associated with systemic inflammation stimulated by cytokines (180, 182). Presumably, 
changes in peripheral body composition could be explained by the proportion of lean 
(muscle) mass induced by physical activity. However, Wilson et al. (2013) reported that 
an increased trunk volume, in comparison, to leg volume was due to the elevated fat mass 
in each body segment, as opposed to the lean mass (183). 
 Wang et al. (2007) utilized a Hamamatsu photonic laser scanner to assess body 
volumes, including total body, trunk, arms, and legs, in class II and III obesity 
participants (n=8 men, 23 =women). These values were compared to those with a BMI < 
35 kg/m2 (184). Men exhibited greater total body, torso, and arm volumes, as well as 
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torso to total body volume ratio than women; women had a higher leg to total body 
volume ratio, irrespective of BMI classifications (184). However, no differences were 
found in leg volume in men and women according to BMI grouping (184). The present 
study identified significantly greater thigh volumes in women, as compared to men. Men 
showed significantly higher total and upper body volumes; whereas, women had greater 
values of lower body volumes and ratios and these findings were consistent across BMI 
groups between men and women. These results correspond to research that has shown 
women are more prone to exhibit a gynoid body shape, as opposed to men that have an 
android body type (115, 116, 171).  
 The research by Wang et al. (2007) also observed that class II and III obese 
participants showed greater total body, torso, arm, leg (women only) volumes, and torso 
to total body volume ratio, and lower leg to total body volume ratio, as opposed to 
subjects with BMI < 35 kg/m2 (184). Similarly, the current study observed that obesity 
class II subjects had greater total body, torso, abdomen-hip, and thigh volume, as 
opposed to other BMI groups including obesity class I, regardless of sex. In addition, 
thigh volumes in obese class II participants were larger than those in other BMI groups, 
but not significant compared to class I. This suggests that the changes in the body volume 
proportions were subtle among moderately and morbidly obese individuals. Greater 
differences may have been observed if our sample had been expanded in size or included 
obesity class III. 
 Wilson et al. (2013) utilized a trunk to leg volume ratio that was determined by 
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DXA as a reflection of body shape index (183). A higher value for this measure indicated 
that the proportion of trunk was greater than the legs, as the upper body volume was 
divided by the lower body volume. The trunk to leg volume ratio increased across 
underweight, healthy weight, and overweight participants (1.40, 1.46, 1.57, respectively) 
(183). This investigation demonstrated that proportions of legs were larger, as compared 
to trunk volume for underweight individuals, and the proportion of leg volume was 
smaller than the trunk volume for higher BMI groups. However, no differences were 
found between the overweight and obese (183). In the current study, upper body volume 
ratios increased according to the BMI classification, while lower body volume ratios 
decreased, regardless of sex. These results also conform to Wang et al. (2007) who found 
that lower body volume factor (leg to total body volume ratio) decreased as BMI 
classification increased (184). Correspondingly, these suggest that a greater lower body 
volume may have a beneficial effect on being obese. Thus, as an individual progresses to 
a higher BMI group, body fat may be more prone to accumulate in the upper body, rather 
than the lower body region.  
 The current investigation confirmed the favorable associations between lower body 
factors and accumulation of visceral adiposity, even after adjustment for age, sex, and 
BMI, as the odds ratios were 0.44 for thigh to torso volume ratio and 0.41 for thigh to 
abdomen-hip volume ratio. It is well established that greater fat deposition in thighs or 
legs is believed to be a protective factor for obesity-related diseases such as 
cardiovascular disease, coronary heart disease, type 2 diabetes (118, 123, 129, 167) or 
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longevity/mortality (123, 127); whereas, fat depots in the upper portion of the body are 
more closely linked to those diseases. In the elderly, Snijder et al. (2003) observed that 
individuals with larger hip and thigh circumferences exhibited a lower risk of type 2 
diabetes occurrences. The odds ratios for prediction of type 2 diabetes for hip and thigh 
circumferences were 0.55 and 0.79 in men; and 0.63 and 0.62 in women, when adjusted 
for age, BMI, and waist circumference (167). In contrast, a larger waist circumference 
was linked to increased incidence of developing type 2 diabetes (167).  
 A study by McLaughlin et al. (2011) confirmed that thigh fat behaves as a potential 
protective factor, as the odds ratios regarding the thigh fat to predict insulin resistance 
was 0.59, after adjustment of sex and BMI (185). Similar findings were observed in 
college students, with leg (but not arm) fat linked to reduction of cardiovascular risk 
factors (p<0.05) (186). In comparison, Hoyer et al. (2011) found that neither mid-thigh 
circumference or subcutaneous thigh fat depot was related to risk of type 2 diabetes 
diagnosis among Japanese Americans; the odds ratios for both were only 0.9 (187) 
(p>0.05).  
 The unique measurements of body volume and body ratios by SBI incorporated in 
this present study provide a means for prediction of visceral adiposity volume. Visceral 
adiposity remains difficult to assess but the 3D SBI utilized in this research permit 
detection of this type of adiposity.  
 In summary, thigh volume in relation to torso and abdomen-hip volume determined 
by SBI were parameters that estimated the risks of possessing visceral adiposity, the 
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metabolically active fat depot. The favorable effects of lower body components on 
visceral fat were apparent in both men and women, despite sex differences in body size 
and shape.  
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CHAPTER 4. PREDICTION OF ANDROID AND GYNOID BODY ADIPOSITY 
VIA A THREE-DIMENSIONAL STEREOVISION BODY IMAGING SYSTEM 
AND DUAL-ENERGY X-RAY ABSORPTIOMETRY 
Abstract 
Current methods for measuring regional body fat are expensive and inconvenient 
compared to the relative cost-effectiveness and ease-of-use of a stereovision body 
imaging (SBI) system. The primary goal of this research is to develop prediction models 
for android and gynoid fat by body measurements assessed via SBI and dual-energy x-ray 
absorptiometry (DXA). Subsequently, mathematical equations for prediction of total and 
regional (trunk, leg) body adiposity were established via parameters measured by SBI 
and DXA. A total of 121 participants were randomly assigned into primary and cross-
validation groups. Body measurements were obtained via traditional anthropometrics, 
SBI, and DXA. Multiple regression analysis was conducted to develop mathematical 
equations by demographics and SBI assessed body measurements as independent 
variables and body adiposity (fat mass and percent fat) as dependent variables. The 
validity of the prediction models was evaluated by a split sample method and Bland-
Altman analysis. The R2 of the prediction equations for fat mass and percent body fat 
were 93.2% and 76.4% for android, and 91.4% and 66.5% for gynoid, respectively. The 
limits of agreement for the fat mass and percent fat were – 0.06 ± 0.87 kg and – 0.11 ± 
1.97 % for android and – 0.04 ± 1.58 kg and – 0.19 ± 4.27 % for gynoid. Prediction 
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values for fat mass and percent fat were 94.6% and 88.9% for total body, 93.9% and 
71.0% for trunk, and 92.4% and 64.1% for leg, respectively. The three-dimensional (3D) 
SBI produces reliable parameters that can predict android and gynoid, as well as total and 
regional (trunk, leg) fat mass.  
 
Introduction 
Measurements of regional body adiposity, such as trunk, thigh, leg, and android 
fat have been linked closely with obesity-related risks. Thus, these regional areas may 
provide more information for assessment of health risks, as compared to overall obesity 
(119, 177-179). This is particularly true with the recent controversy of the efficiency of 
BMI for predicting obesity-related disease risks (90). One of the previous reports 
involved with regional adiposity related-risks included android and gynoid fat determined 
via dual-energy x-ray absorptiometry (DXA) (131, 188, 189). The android adiposity 
showed a positive correlation with visceral adiposity (r=0.81, p<0.01), as well as strong 
associations with metabolic risk factors including triglycerides, homeostatic model 
assessment of the insulin resistance (HOMA-IR), fasting glucose and insulin (188). These 
relationships were even stronger when compared to visceral adiposity assessed by 
computed tomography (CT) (188). In addition, gynoid fat assessed by DXA 
demonstrated decreased risks for stroke (189) and metabolic risk factors (131). Thus, the 
ability to predict regional fat distribution, such as android and gynoid fat in an 
inexpensive and easy manner, would be advantageous for estimating risks associated with 
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obesity-related diseases in the general population. 
Instruments that assess regional body adiposity via advanced techniques include 
CT (59), DXA (58, 190) and magnetic resonance imaging (MRI) (190). In CT, the 
differences in the attenuation of X-rays through tissues permits imaging of internal body 
structures (59). For DXA, a three-compartment model estimates body composition using 
varying attenuations of X-rays through bones, lean tissue, and fat (58, 62). For the MRI, 
the basis for production of high quality, 3 dimensional (3D) anatomic images is an 
abundance of hydrogen nuclei (70). Both CT and DXA involve the usage of radiation 
during assessment, and DXA is not always possible in morbidly obese subjects due to 
limits on weight and size (50, 53). Moreover, CT, DXA and MRI are restricted for large 
scale epidemiological studies that measure a large number of subjects in a given time 
frame across various locations. All of these methods lack portability, are bulky, and 
expensive to operate. Thus, more precise, non-invasive, and low cost methods are needed 
to estimate regional body adiposity.  
Previously, body measurements assessed by photonic stereovision body imaging 
(SBI) were effective in the development of prediction equations for abdominal adiposity 
determined by MRI (149). The established equations were useful in predicting abdominal 
adiposity volumes, including total abdominal, subcutaneous, and visceral adiposity, 
which could replace the MRI and improve the efficiency of assessing abdominal 
adiposity in field settings. The current project utilized a 3D SBI system as an assessment 
method for body composition (138, 148), and compared it to android and gynoid fat as 
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determined by DXA. The advantages of SBI as an evaluative method are: 1) it is a 
quantifiable, visual representation of body size and shape (Figure 4.1); 2) the degree of 
central obesity can be documented by central obesity depth and width (149); 3) it utilizes 
a rapid and non-invasive (no radiation exposure) method to obtain various body 
measurements; and 4) it is cost-effective and portable.  
The primary objective of this research was to develop prediction equations for 
android and gynoid body adiposity assessed via 3D photonic SBI and DXA. Additionally, 
mathematical models for total body, trunk and leg adiposity were established via 
parameters measured with SBI and DXA.  
 
Method and Procedures 
Design of Study 
A total of 121 adults, including 67 men and 54 women, were enrolled in this body 
composition study. Inclusion criteria for participation were healthy Caucasian or non-
White Hispanic men and women, ages 19-65 years old, and BMI category of healthy 
weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), or obese (>30 kg/m2). Subjects 
with any known diseases and women who are or could be pregnant, or lactating were 
excluded. Informed consent documents were obtained from participants and the risks and 
benefits of the study were explained and informed consents were obtained. The 
University of Texas at Austin Institutional Review Board approved the study.  
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Subjects were instructed to restrict consumption of caffeine and alcohol, as well 
as heavy exercise at least 10 hours prior to the visit. Study participants completed 
demographic and health questionnaires and then were assessed for traditional 
anthropometrics, SBI, and DXA.  
 
Assessment of Body Composition 
Body composition assessment procedures and descriptions of the devices, 
including traditional anthropometrics and SBI were described previously (149). 
Traditional anthropometrics evaluated weight and height, and BMI was calculated as 
weight in kg divided by height in m2.  
Body circumferences, central obesity measures, and total/regional body volumes 
and ratios (upper- and lower- body volume ratio factors) were assessed via 3D SBI. SBI 
utilizes a method of photogrammetry in order to acquire the body images of an 
individual. Four pairs of CMOS cameras (Videre Design, Menlo Park, CA) capture the 
image of the body, while four LCD projectors (NEC Corporation, Tokyo, Japan) 
illuminate the body surface (149). Body circumferences assessed via SBI included chest, 
waist, hip, upper thigh, lower thigh and knee. Regional body volumes encompassed torso 
(neck to crotch), abdomen-hip (smallest point of waist to crotch), and thigh (crotch to 
mid-thigh). Upper-body volume factors involved volume ratios of torso to total body, 
abdomen-hip to total body, and abdomen-hip to torso. Lower-body volume factors 
included volume ratios of thigh to total body, thigh to torso, and thigh to abdomen-hip. 
 
 
 
 
 
 
   
 
118 
Measurements for both central obesity depth and width were taken at the umbilicus level. 
Central obesity width was defined as the widest length on the coronal plane; central 
obesity depth, as the length between the mid-point of central obesity width and the 
umbilicus (149). Waist-to-hip ratio was computed as waist circumference (cm) divided 
by hip circumference (cm) and waist-to-thigh ratio was obtained as waist circumferences 
(cm) divided by upper thigh circumference (cm).  
DXA was utilized to measure body composition, including android, gynoid, total 
body, trunk, and leg fat mass, fat-free mass and percent body fat via a Lunar Prodigy (GE 
Medical Systems, Madison, WI). Subjects laid flat on the scanner table where the X-ray 
sources were located. All were wearing light weight clothing and metals were removed. 
The scanning process required 7 to 20 minutes, depending on the size of the subject. The 
DXA device scans the whole body by interacting with the main computer, using two 
different energy levels of X-ray beams. These two varying levels of energy go through 
the body in diverse raster patterns so that the bone mineral density of the spine, hip, 
forearms and the soft tissues of the whole or specific area (trunk, leg) are measured.  
This research focused on android and gynoid fat. For the DXA, the android region 
was defined as the area between the ribs and the pelvis, and was completely covered by 
the trunk region. The upper demarcation was 20% of the distance from the iliac crest and 
the neck; whereas, the lower demarcation was at the top of the pelvis. The gynoid region 
included the area of the hips and the upper thighs, and it overlapped the leg and trunk 
areas. For this region, the upper demarcation was below the top of the iliac crest at a 
 
 
 
 
 
 
   
 
119 
distance of 1.5 times the android height. The total height of the gynoid region was two 
times the height of the android region (191). Android and gynoid fat regions were 
computed via Prodigy enCORE software (version 11.0, GE Medical Systems) provided 
by the manufacturer. The regions of android and gynoid fat depots in men and women 
that were assessed by DXA are depicted in Figure 4.1.  
 
Analysis of Statistics 
Participants characteristics including demographics (age, sex), traditional 
anthropometrics (weight, height, BMI), SBI, and DXA measurements of overall, primary, 
and cross-validation groups were computed as a measure of descriptive statistics and 
expressed as mean ± standard error of mean (Table 4.1). Comparisons between primary 
and cross-validation groups were conducted by one-way analysis of variance (ANOVA). 
The normality of the distributions of quantitative variables was evaluated by histograms 
and the Kolmogorov-Smirnov test.  
Stepwise multiple linear regression analysis utilized body fat mass (kg) and fat 
percentages (%) (android, gynoid, total body, trunk, leg) derived via DXA as dependent 
variables, and relevant body measurements assessed by demographics (age, sex) and SBI 
as independent variables. Independent parameters encompassed ratios of waist to hip, 
waist to thigh circumferences; circumferences of waist, hip, upper thigh, lower thigh and 
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Figure 4.1. Body images of men and women determined by a three-dimensional 
stereovision body imaging and matched figures of dual-energy x-ray absorptiometry, 
illustrating android and gynoid fat areas 
a) Men, BMI 30.8 kg/m2 
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(b) Women, BMI 30.2 kg/m2 
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knee; volumes of total body, torso, abdomen-hip and thigh; volume ratios of torso to total 
body, abdomen-hip to total body, thigh to total body, abdomen-hip to torso, thigh to torso 
and thigh to abdomen-hip. Central obesity depth and width were calculated to construct 
prediction models for body adiposity. The impact of demographics, including age and 
sex, also were included as independent variables in order to examine the associations 
with android and gynoid body adiposity.  
A dummy code was used to label sex as women=0 and men=1 and ethnicity as 
non-White Hispanic =0 and Caucasian=1. The total participants (n=121) were randomly 
assigned via the statistics software into primary (n=77, 65%) and cross-validation (n=44, 
35%) groups. The prediction equations were developed by using the primary group. In 
addition, Bland-Altman limits of agreement analysis was implemented to confirm the 
validity of the developed equations and to visualize the mean differences and 95% limits 
of agreement for the bias between observed values measured by DXA and predicted 
values by the equation models (192). Standardized !-coefficients (!) described the output 
of stepwise multiple regression analysis, which explains the change in terms of the 
standard deviation unit of the dependent variable that is associated with one standard 
deviation increase in the independent variable. Variables with a variance inflation factor 
greater than 10 were eliminated to reduce the impact of collinearity between the 
parameters.
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Table 4.1. Demographics and body composition of primary and cross-validation groups 
  Group   
Parameters 
Overall 
Participants 
(n=121) 
 Primary                     
(n=77) 
 Cross-Validation                
(n=44) 
 p-valueb 
 Mean ± SEMa  Mean ± SEMa  Mean ± SEMa   
Demographics        
Age (years) 34.38 ± 0.98 33.75± 1.27  35.49 ± 1.51  0.39 
Sex (%Men/%Women) 55.4/44.6 57.1/42.9 52.3/47.7 0.61 
Ethnicity (%Caucasian/Hispanic) 65.3/34.7 
 
61.0/39.0 
 
72.7/27.3 
 
0.20 
Traditional Anthropometrics        
Weight (kg) 81.63 ± 1.63  81.71 ± 2.04   81.50 ± 2.75  0.95 
Height (cm) 170.34 ± 0.85  169.97 ± 1.00  170.99 ± 1.54  0.56 
BMI (kg/m2) 28.02 ± 0.49  28.24 ± 0.62  27.65 ± 0.77  0.57 
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Table 4.1 (continued)        
Stereovision Body Imaging         
Circumference (cm)        
Waist  91.33 ± 1.27  91.26 ± 1.55  91.46 ± 2.22  0.94 
Hip  109.30 ± 1.06  109.45 ± 1.46  109.04 ± 1.43  0.85 
Upper thigh 63.81 ± 0.75  63.85 ± 1.03  63.74 ± 1.03  0.94 
Lower thigh 42.53 ± 0.47  42.74 ± 0.63  42.16 ± 0.71  0.56 
Knee 35.76 ± 0.35  35.75 ± 0.43  35.78 ± 0.59  0.97 
Circumference ratio        
Waist-to-hip  0.85 ± 0.01  0.85 ± 0.01  0.85 ± 0.01  0.90 
Waist-to-thigh 1.43 ± 0.02  1.43 ± 0.02  1.43 ± 0.04  0.92 
Central obesity measure (cm)        
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Table 4.1 (continued)        
Central obesity depth  15.63 ± 0.34  15.48 ± 0.43   15.89 ± 0.58  0.56 
Central obesity width  35.35 ± 0.46  35.30 ± 0.59  35.44 ± 0.74  0.88 
Volume (L):        
Total body  77.14 ± 1.64  77.13 ± 2.04  77.16 ± 2.78  0.99 
Torso  36.97 ± 1.01  36.95 ± 1.27  37.01 ± 1.69  0.98 
Abdomen-hip  27.60 ± 0.84  27.46 ± 1.09  27.83 ± 1.33  0.83 
Thigh  4.41 ± 0.12  4.39 ± 0.15  4.44 ± 0.21  0.83 
Volume ratio:        
Torso to total body  0.47 ± 0.00  0.47 ± 0.00   0.47 ± 0.01  0.97 
Abdomen-hip to total body  0.35 ± 0.00  0.35 ± 0.01  0.36 ± 0.01  0.44 
Abdomen-hip to torso  0.74 ± 0.01  0.74 ± 0.01   0.75 ± 0.01  0.17 
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Table 4.1 (continued)        
Thigh to total body  0.06 ± 0.00  0.06 ± 0.00  0.06 ± 0.00  0.54 
Thigh to torso  0.13 ± 0.00  0.12 ± 0.00  0.13 ± 0.01  0.45 
Thigh to abdomen-hip  0.17 ± 0.01  0.17 ± 0.01   0.17 ± 0.01  0.79 
Dual-energy X-ray Absorptiometry        
Fat mass (kg):        
Android  2.77 ± 0.15  2.79 ± 0.19  2.72 ± 0.23  0.80 
Gynoid  5.06 ± 0.21  5.07 ± 0.28  5.04 ± 0.29  0.96 
Total body  27.46 ± 1.23  27.61 ± 1.61  27.22 ± 1.86  0.88 
Trunk  15.30 ± 0.70  15.33 ± 0.92  15.25 ± 1.08  0.96 
Legs  9.28 ± 0.46  9.37 ± 0.60  9.12 ± 0.72  0.79 
Percent body fat (%):        
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Table 4.1 (continued)        
Android  9.89 ± 0.19  10.00 ± 0.22  9.69 ± 0.37  0.44 
Gynoid  20.11 ± 0.34  19.96 ± 0.40  20.36 ± 0.64  0.58 
Total body  32.44 ± 1.09  32.28 ± 1.41  32.74 ± 1.70  0.84 
Trunk  56.85 ± 0.64  56.89 ± 0.74  56.78 ± 1.20  0.94 
Legs  35.36 ± 0.62  35.25 ± 0.72  35.54 ± 1.17  0.83 
 
a Standard error of mean 
b Significant level determined by one-way analysis of variance (ANOVA) 
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All statistical analysis and data management was performed using Predictive 
Analytics Software Statistics 18.0 (IBM SPSS, Chicago, IL). A p-value of less than 0.05 
was adopted as a statistically significant level.  
 
Results 
Description of Statistics 
Participants’ characteristics and body composition for overall, primary, and cross-
validation groups are described in Table 4.1. The study sample included men and 
women, whose age and BMI ranged from 18 to 65 years and 18 to 40 kg/m2, respectively. 
None of the parameters were significantly different among participants in the primary and 
cross-validation groups (p>0.05).  
 
Prediction Equations for Android and Gynoid Body Fat  
The final equations for prediction of android and gynoid body adiposity are 
presented in Table 4.2. Changes of prediction value of R2 and 
unstandardized/standardized B of the demographics and body parameters determined by 
SBI that were included in the final prediction models for body fat mass and percent body 
fat are shown in Table 4.3. The prediction equations for body fat mass (kg) resulted in 
higher prediction values (93.2% for android and 91.4% for gynoid), as opposed to the 
prediction of percent body fat (76.4% for android and 66.5% for gynoid). The android 
and gynoid fat mass and percent fat equations were composed of a combination of sex,
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Table 4.2. Final prediction equations for total and regional body fat mass and percentages via demographics, dual-energy x-ray 
absorptiometry and stereovision body imaging 
Primary Group  Validation Group Dependent 
Variablea 
Predictive Modelsb 
R2 (%) SEEc  ME (CI)d 
Fat Mass (kg) 
Android 
– 2.54 + 0.10 Torso Volume – 0.65 Sex + 0.13 Central Obesity 
Depth 
93.2* 0.44  – 0.17 (– 1.04, 0.70) 
Gynoid 
– 5.74 + 0.13 Upper Thigh Circumference + 0.12 Abdomen-Hip 
Volume – 1.35 Sex 
91.4* 0.74  – 0.12 (– 1.93, 1.69) 
Total 
– 18.85 + 1.25 Central Obesity Depth +2.07 Thigh Volume – 8.37 
Sex + 0.62 Torso Volume 
94.6* 3.39  – 1.09 (– 13.13, 10.95) 
Trunk 
– 10.60 + 0.86 Central Obesity Depth + 0.41 Torso Volume – 4.10 
Sex 
93.9* 2.03  – 0.66 (– 5.18, 3.86) 
 
 
 
 
 
 
   
 
130 
Table 4.2 (continued)     
Leg 
– 16.85 + 0.15 Upper Thigh Circumference + 0.53 Knee 
Circumference –3.42 Sex – 26.13 Thigh to Abdomen-Hip Volume 
Ratio + 0.92 Thigh Volume 
92.4* 1.50  – 0.39 (– 3.52, 2.75) 
Percent Fat (%) 
Android 
5.72 – 18.13 Thigh to Abdomen-Hip Volume Ratio + 7.23 Waist to 
Hip Circumference Ratio + 0.08 Central Obesity Depth 
76.4* 0.96  – 0.31 (– 2.46, 1.85) 
Gynoid 
54.90 – 15.48 Waist to Thigh Circumference Ratio – 0.22 Upper 
Thigh Circumference + 1.68 Sex 
66.5* 2.08  0.53 (– 4.15, 5.21) 
Total 
– 1.89 + 2.01 Central Obesity Depth – 12.98 Sex + 1.53 Thigh 
Volume 
88.9* 4.22  – 1.47 (– 9.12, 6.19) 
Trunk 
31.62 + 39.14 Waist to Hip Circumference Ratio – 63.48 Thigh to 
Torso Volume Ratio 
71.0* 3.55  0.20 (– 7.73, 8.13) 
Leg 
47.45 – 13.92 Waist to Thigh Circumference Ratio + 44.92 Thigh 
to Abdomen-Hip Volume Ratio 
64.1* 3.81  0.21 (– 8.12, 8.54) 
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a Dependent variables (body fat mass and fat percentages) measured by dual-energy X-ray absorptiometry. 
b Independent variables measured by stereovision body imaging. Body measurements include sex, age, upper thigh 
circumference, knee circumference, stereovision waist to hip circumference ratio, waist to thigh circumference ratio, total body 
volume, torso volume, abdomen-hip volume, thigh volume, torso volume to total body volume ratio, abdomen-hip volume to 
total body volume ratio, thigh volume to total body volume ratio, abdomen-hip ratio to torso volume ratio, thigh volume to 
torso volume ratio, thigh volume to abdomen-hip volume ratio, central obesity depth and central obesity width. 
c SEE, Standard error of the estimate 
d Mean error = observed – predicted (confidence interval) 
* Correlation is significant at 0.05 level (2-tailed) 
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Table 4.3. Changes of R2 and B values of the demographics and stereovision body imaging parameters included in the 
prediction equations for total and regional adiposity fat mass and percent fat 
Body Fata Parametersb R2 Change (%) Unstandized B Standardized B p-value 
Fat Mass (kg)     
Android Torso Volume 85.5 0.10 0.66 <0.001 
 Sex  6.0 – 0.65 – 0.20 <0.001 
 Central Obesity Depth 1.7 0.13 0.31 <0.001 
Gynoid Upper Thigh Circumference 81.7 0.13 0.46 <0.001 
 Abdomen-Hip Volume 5.2 0.12 0.47 <0.001 
 Sex  4.5 – 1.35 – 0.27 <0.001 
Total Body Central Obesity Depth 76.8 1.25 0.33 <0.001 
 Thigh Volume 12.3 2.07 0.19 <0.001 
 Sex  2.4 – 8.37 – 0.29 <0.001 
 Torso Volume 3.1 0.62 0.48 <0.001 
Trunk Central Obesity Depth 85.7 0.86 0.40 <0.001 
 Torso Volume 2.7 0.41 0.56 <0.001 
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Table 4.3 (continued)     
 Sex  5.6 – 4.10 – 0.25 <0.001 
Leg Upper Thigh Circumference 82.4 0.15 0.26 0.002 
 Knee Circumference 3.3 0.53 0.38 <0.001 
 Sex  3.6 – 3.42 – 0.33 <0.001 
 
Thigh to Abdomen Hip Volume 
Ratio 
2.5 – 26.13 – 0.26 <0.001 
 Thigh Volume 0.6 0.92 0.22 0.02 
Percent Fat (%)     
Android 
Thigh to Abdomen Hip Volume 
Ratio 
69.6 – 18.13 – 0.49 <0.001 
 Waist to Hip Circumference Ratio 5.2 7.23 0.33 <0.001 
 Central Obesity Depth 1.5 0.08 0.16 0.03 
Gynoid Waist to Thigh Circumference 
Ratio 
33.3 – 15.48 – 0.96 <0.001 
 Upper Thigh Circumference 29.5 – 0.22 – 0.55 <0.001 
 Sex  3.7 1.68 0.24 0.006 
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Table 4.3 (continued)     
Total Body Central Obesity Depth 53.8 2.01 0.61 <0.001 
 Sex  33.4 – 12.98 – 0.52 <0.001 
 Thigh Volume 1.6 1.53 0.16 0.002 
Trunk Waist to Hip Circumference Ratio 65.9 39.14 0.54 <0.001 
 Thigh to Torso Volume Ratio 5.0 – 63.48 –3.56 0.001 
Leg Waist to Thigh Circumference 
Ratio 
57.9 – 13.92 – 0.48 <0.001 
 
Thigh to Abdomen Hip Volume 
Ratio 
6.2 44.92 0.37 0.001 
 
a Dependent variables (body fat mass and fat percentages) measured by dual-energy X-ray absorptiometry. 
a Independent variables measured by stereovision body imaging. Body measurements include sex, age, upper thigh 
circumference, knee circumference, stereovision waist to hip circumference ratio, waist to thigh circumference ratio, total body 
volume, torso volume, abdomen-hip volume, thigh volume, torso volume to total body volume ratio, abdomen-hip volume to 
total body volume ratio, thigh volume to total body volume ratio, abdomen-hip ratio to torso volume ratio, thigh volume to 
torso volume ratio, thigh volume to abdomen-hip volume ratio, central obesity depth and central obesity width. 
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Figure 4.2. Bland-Altman analysis of agreement for prediction of android and gynoid fat mass and percent fat by stereovision 
body imaging and measured values by dual-energy x-ray absorptiometry. The solid line in the middle represents the mean 
values and two dotted lines stand for upper and lower limits of agreement (mean ± 1.96 standard deviation). 
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 (a) Android fat mass (kg) 
 
  
 
-1.5 
-1 
-0.5 
0 
0.5 
1 
1.5 
0 1 2 3 4 5 6 
D
iff
er
en
ce
s i
n 
ob
se
rv
ed
 a
nd
 p
re
di
ct
ed
 v
al
ue
s (
kg
) 
Average of observed and predicted values (kg) 
 
 
 
 
 
 
   
 
137 
(b) Android fat percentage (%) 
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(c) Gynoid fat mass (kg) 
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(d) Gynoid fat percentage (%) 
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upper thigh circumference, thigh to abdomen-hip volume ratio, waist to hip ratio, waist to 
thigh circumference ratio, volumes of torso and abdomen-hip, and/or central obesity 
depth. 
Torso volume, sex and central obesity depth were identified for the prediction of 
android fat mass (R2=93.2%). For prediction of gynoid fat mass, upper thigh 
circumference, abdomen-hip volume and sex were selected (R2=91.4%). Among the 
independent variables, SBI-measured thigh to abdomen-hip volume ratio, waist to hip 
ratio and central obesity depth were found to be the most effective parameters that 
explained android percent body fat, with a R2 of 76.4%. Similarly, waist to thigh 
circumference ratio, upper thigh circumference and sex were identified in the stepwise 
multiple regression analysis for gynoid percent fat (R2=66.5%).  
 
Prediction Equations for Total and Regional Body Fat  
The prediction equations for body fat mass (kg) computed higher prediction 
values (R2 from 92.4 to 94.6%), as opposed to the prediction of percent body fat (R2 from 
64.1 to 89.9%) (Table 4.2). Each equation contained from three to five parameters, 
including sex; circumferences of upper thigh and knee; circumference ratios of waist to 
hip and waist to thigh; volumes of torso and thigh; volume ratios of thigh to torso, thigh 
to abdomen-hip; and/or central obesity depth. Total body fat exhibited the highest 
prediction values of 94.6 and 88.9% for fat mass and percent body fat.  
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Central obesity depth was the most effective parameter for predicting total body 
fat mass. Also, sex, thigh and torso volumes were included in the model, which resulted 
in the highest R2 value of 94.6%. Parameters that explained the highest proportions of 
total percent body fat were central obesity depth, sex and thigh volume. Central obesity 
depth and thigh volume showed a positive association with total percent body fat 
(p<0.05). The explained proportion of the total percent body fat was 88.9%, which was 
the highest compared to other percent body fat models. 
For the trunk fat mass, central obesity depth, torso volume and sex were included 
in the final model (R2=93.9%). For the trunk percent fat, waist to hip circumference ratio 
and thigh to torso ratio determined by SBI were identified as crucial parameters that 
explained 71.0%. The direction of the standardized !-coefficients showed that having a 
greater waist to hip circumference ratio (!=0.54, p<0.001) and lower thigh to torso ratio 
(!=-3.56, p=0.001) contributed to an increase in trunk percent fat (p<0.05) (Table 4.3). 
Circumferences of the upper thigh and knee, as well as sex, thigh to abdomen-hip 
volume ratio, and thigh volume were selected in the prediction model for leg fat mass (R2 
of 92.4%). Significant effects of waist to thigh circumference ratio and SBI measured 
thigh to abdomen-hip volume ratio were detected by regression analysis for leg percent 
fat, which explained 64.1% of its proportions (p<0.05). 
 
Cross Validation for the Prediction Equations for Body Fat Mass and Percent Fat 
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The prediction equations that were developed for estimation of body adiposity by 
using the primary group were then applied to the cross-validation group in order to 
confirm the cross-validity of the developed mathematical models. All of the 95% 
intervals for the mean error (observed value – predicted value) encompassed zero, which 
assured that the body fat assessed via DXA and predicted body fat by the equation were 
not statistically different (Table 4.2).  
Figure 4.2 depicts the mean value (solid line) and 95% limits of agreement 
(dotted lines) of android (Figure 4.2a,b) and gynoid (Figure 4.2c,d) fat mass and percent 
fat via Bland-Altman analysis to examine the absence of systematic bias between 
observed values assessed by DXA and predicted values computed by prediction 
equations. Data were randomly dispersed without distinctive patterns within the 95% 
limits of agreement, which ensured the validity of the prediction equations. The limits of 
agreement for fat mass and percent fat were – 0.06 ± 0.87 kg and – 0.11 ± 1.97 % for 
android and – 0.04 ± 1.58 kg and – 0.19 ± 4.27 % for gynoid, respectively (Figure 4.2). 
A few outliers were observed in the Bland-Altman plots; however, these were not due to 
data error. 
 
Discussion  
The high R2 values for the equations of android (93.2%) and gynoid (91.4%) 
adiposity suggested that SBI is a reliable and effective system that can be used to 
estimate regional body fat mass. This research was the first to develop prediction 
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equations for android and gynoid adiposity by incorporating body measurements derived 
via 3D SBI compared to DXA. 
 Previous studies showed that the upper body fat, such as trunk and android fat, are 
associated with increased obesity-related risk factors; whereas, lower body fat including 
thigh, leg and gynoid fat are linked with decreased risk factors (119, 131, 177-179, 189, 
193). Particularly, android and gynoid fat determined by DXA showed inverse 
relationships with metabolic risk factors, in which android fat exhibited a positive 
association; whereas, gynoid fat deposition had decreased risks (131, 193). In the current 
research, sex was included in the prediction equations for android and gynoid fat mass, as 
well as gynoid percent fat, as these reflected the differences in body size and shape 
between men and women. Moreover, central obesity depth acquired by SBI was entered 
in the mathematical models for android fat mass and percent fat, implying that this 
parameter can be used effectively as a surrogate measurement of central obesity. Finally, 
upper thigh circumference was selected as one of the variables for the prediction of 
gynoid adiposity fat mass and percent fat. Note that these types of body measurements 
(upper thigh circumference) cannot be obtained easily without physical contact. The 
ability to create these measurements electronically reflects the practicality of SBI.  
 Previous studies have indicated that accumulation of percent fat in the lower body 
has a protective effect on adiposity-related risk factors, in comparison to fat deposition in 
the upper body area (130, 193, 194). For instance, large trunk fat measured via DXA was 
associated with increased insulin resistance in European (r=0.40, p<0.05) (177) and 
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elderly women (ß=0.65, p<0.05) (119). Trunk fat also was related to greater fasting 
glucose and post-load glucose in elderly men (ß=0.44, p<0.05, ß=0.41, p<0.05) and 
women (ß=0.49, p<0.05, ß=0.47, p<0.05) (119). In contrast, Zhang et al. (2013) indicated 
that leg percent fat was negatively linked with adiposity-related risk factors including 
triacylglycerol, and diastolic blood pressure among adults (p<0.05) (130). Leg percent fat 
was associated with decreased risks for metabolic syndrome, as the odds ratios for lowest 
to the highest quintile was 0.22 (130). Correspondingly, Hara et al. (2004) illustrated 
protective effect of leg percent fat on coronary atherosclerosis while trunk percent fat was 
associated with increased risks for coronary atherosclerosis (194). Thus, determination of 
the body fat, especially total and regional body fat mass, in an easy and efficient manner 
via 3D SBI would improve assessment of clinical health risks. 
Previous studies have utilized anthropometric body measurements to develop 
prediction equations for total and regional adiposity (195-200). Yavari et al. (2011) used 
body weight to estimate total fat mass (fat mass = 0.59 weight – 16.5; R2=98%) and trunk 
fat (trunk fat = 0.32 weight – 11.1; R2=96%) derived by DXA in women with type 2 
diabetes, metabolic syndrome, and healthy participants (195). Ritchie and Davidson 
(2011) also used simple body measurements [weight, height, BMI, body circumferences 
(chest, waist, hip, upper and lower legs)] to predict regional body fat mass assessed by 
DXA. The R2 for the models were 84.3 and 82.9% for chest; 85.1 and 80.4% for waist; 
76.1 and 82.5% for hips; 72.6 and 73.4% for upper legs in men and women, respectively 
(197). In addition, Scafoglieri et al. (2013) reported the prediction equations for trunk and 
 
 
 
 
 
 
   
 
145 
leg regional adiposity. The R2 were 92 and 94% for trunk fat mass and 91 and 86% for 
trunk percent fat; 94 and 85% for leg fat mass and 76 and 69% for leg percent fat in men 
and women, respectively (198). Prediction equations by Scafoglieri et al. (2013) utilized 
numerous anthropometric measurements, by manual methods, such as weight, height, 14 
body circumferences via measurement tape, 13 skinfold thicknesses, and 4 bone breadths 
to develop the prediction equation while regional body fat was assessed by DXA (198). 
This degree of preciseness yields excellent results, but may not be practical for fast 
screening of populations. 
The present research proposed mathematical equations for the prediction of total 
and regional (trunk, leg) adiposity (fat mass and percent fat) by integrating body 
measurements derived via an efficient and rapid method, a 3D photonic SBI. The R2 of 
the prediction equations for total body, trunk and legs were 94.6, 93.9, and 92.4% for fat 
mass; and 88.9, 71.0 and 64.1% for percent body fat, respectively. These predictive 
values for total and regional (trunk, leg) fat mass, but not fat percentage, were relatively 
high compared to other equations calculated from previously reported models. This result 
implied that the relationship between percent body fat and SBI measured parameters were 
not as close as with body fat mass. These low prediction values indicate that the body 
parameters incorporated for the equations are not effective surrogate measurements for 
percent body fat. A greater number of more elaborate measurements as indicated by 
Scafoglieri et al. (2013) may be helpful (198).  
 The parameters of regional body volumes and central obesity depth that were used 
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in this study are unique because simple anthropometric assessment tools cannot easily 
discern these measurements. In particular, central obesity depth previously has been 
utilized as a promising indicator of abdominal obesity (149). This variable was selected 
as an effective predictor for fat mass of total body (R2 change 76.8%), and trunk (R2 
change 85.7%), as well as percent body fat of total body (R2 change 53.8%). More 
specifically, increased values of central obesity depth were linked closely with greater 
accumulation of the total and regional adiposity (trunk fat mass).  
 Sex was the one of the most critical components that was incorporated in most of 
the equations. This finding confirms the disparities of the total and regional adiposity 
distribution between men and women. However, age was not included in any of the 
prediction models due to the existence of other stronger variables that were included in 
the models, such as body volumes and central obesity measurements.  
 In the current research, measurements, such as upper thigh circumference, that 
cannot be easily measured were incorporated in the prediction equation models. 
Additionally, the prediction equations derived from this research by SBI are more 
practical than other methods because the parameters assessed by the photonic device did 
not require any physical contact between the subject and researcher. Also, subject burden 
during assessment is substantially reduced because a large amount of information can be 
collected within a one second data acquisition period, Finally, the SBI system removes 
concerns regarding inter and intra-rater reliability, which is problematic in traditional 
anthropometric measurements (39). 
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The 3D surface imaging of the human body has received considerable attention 
due to its broad range of applications, such as body composition assessment in the 
clothing industry (133), animation in movies and computer games (117), 3D face 
recognition in biometrics (201), skin scanning in dermatology and cosmetics (135), and 
planning and evaluation of facial and breast plastic surgery (137). In recent years, this 
technique has been integrated for obesity assessment as the technique is easy-to-use, safe, 
cost-effective, and accurate (138). This laboratory previously used 3D laser body scanner 
to assess body composition, including waist and hip circumferences (165), and body 
volume (202). The ability to measure body volume compared to hydrodensitometry was 
highly accurate with a correlation between these two methods of 0.99 (p<0.01) and an 
intraclass correlation coefficient of 0.99 (p<0.01) (202). In addition, the efficacy of body 
measurements derived via the 3D photonic imager has been confirmed by predicting 
abdominal adiposity volume assessed by MRI, as the R2 values were 89.9, 90.4, and 
71.7% for total abdominal, abdominal subcutaneous and abdominal visceral adiposity, 
respectively (149).  
A limitation of this study was the lower prediction values for total and regional 
(android, gynoid, trunk, leg) percent fat (R2 ranging from 66.5 to 88.9%), as compared to 
total and regional fat mass (R2 ranging from 91.4 to 94.6%). This implies that better body 
measurements are required to establish mathematical models for body fat percentage. 
Yet, the mathematical model for percent total body fat exhibited relatively high 
prediction value (R2 =88.9%), as opposed to other percent fat equations. Due to the small 
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sample size, men and women were combined and analyzed together to create the 
prediction equations. Prediction equations may have been more precise if the analysis 
was conducted separately. Moreover, ethnicity was not included as a factor for 
establishing prediction equation due to the small number of non-White Hispanics, as 
opposed to Caucasians.  
 In summary, SBI assessed body measurements were effective in developing 
prediction equations for android (R2=93.2) and gynoid (R2=91.4) body, as well as total 
(R2=94.6), trunk (R2=93.9), leg fat mass (R2=92.4) and total body fat percentage 
(R2=88.9). This study confirmed the efficacy of SBI as a reliable instrument that provides 
information regarding body composition in an efficient and practical manner. The strong 
predictive values for assessment of android and gynoid, as well as total and regional 
(trunk, leg) body fat mass suggest that this state-of-the-art instrument could be utilized in 
field settings to inform consumers on their body status and disease risks. It is believed 
that the ability to predict regional fat distribution via SBI in an inexpensive and easy 
method will be advantageous for estimating risks associated with obesity-related diseases 
in the general population. 
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CHAPTER 5. CONCLUSIONS 
 
Outcomes of Specific Aims 
The primary purpose of this research was to enhance the assessment of total, 
central, and regional body composition by comparing a three-dimensional (3D) 
stereovision body imaging (SBI) system versus the “gold standards” of magnetic 
resonance imaging (MRI), air displacement plethysmography (ADP), and dual-energy x-
ray absorptiometry (DXA).  
An innovation of this research is the utilization of SBI for body composition 
assessment of abdominal obesity. The SBI is low cost in comparison to other methods. It 
is fabricated by four pairs of monochromatic CMOS cameras (Videre Design, Menlo 
Park, CA; with a resolution of 1280 ! 960 with four ultrashort throw NEC 575VT LCD 
projectors (NEC Corporation, Tokyo, Japan) (138). The projectors are required to 
illuminate the skin to create artificial textures on the subject, while the cameras capture 
the surface area of the body figure. Both cameras and projectors are interfaced with the 
computer, which synchronize their actions. Multiple units are needed to cover the whole 
body in a limited space and to produce higher resolution of images. Each stereo pair will 
generate a 3D surface of the covered region (138). The data acquisition time required for 
obtaining 3D body figures composed of more than 1 million data points is brief, as the 
subject remains motionless for only 200 milliseconds per scan. The 3D SBI is believed to 
be an effective and rapid method for the evaluation of body composition of abdominal 
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obesity. It easily collects diverse body measurements, including volumes, length, breadth, 
and central obesity parameters, via a low-cost, non-invasive method.  
The first aim of the research was to develop mathematical models for the 
prediction of total abdominal, subcutaneous, and visceral adiposity using measurements 
derived via traditional anthropometrics, SBI, and a combination of both. These three 
different approaches for independent predictors were used to establish prediction 
equations for abdominal adiposity, which was the dependent variable. Equations that 
contained the strongest predictor variables were selected as the optimal means for 
predicting total abdominal, subcutaneous and visceral fat. The independent variables 
included (a) traditional anthropometric body measurements and demographics; (b) SBI 
parameters and demographics; and (c) a combination of traditional anthropometrics, SBI 
measurements, and demographics. The dependent variables were volumes of total 
abdominal, subcutaneous and visceral adiposity measured via MRI. The best total fat for 
abdominal adiposity prediction equation was selected by traditional anthropometrics: – 
470.28 + 7.10 waist circumference – 91.01 sex + 5.74 sagittal diameter. The associated 
R2 was 89.9%. For subcutaneous adiposity, the best fat prediction equation was produced 
by a combination method of traditional anthropometrics and SBI: – 172.37 + 8.57 waist 
circumference – 62.65 sex – 450.16 stereovision waist-to-hip ratio. This combination 
method had a R2 of 90.4%. For visceral adiposity, the best fat prediction equation was 
established by a SBI method that included the sex of the person: – 96.76 + 11.48 central 
obesity depth – 5.09 central obesity width + 204.74 stereovision waist-to-hip ratio – 
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18.59 sex. The corresponding R2 was 71.7%.  
The use of SBI did not improve the R2 for the total abdominal and subcutaneous 
adiposity equation models. Yet the prediction values for visceral adiposity increased 
significantly when parameters derived via SBI were applied to the equations. It should be 
noted that the final prediction equation for visceral adiposity has two parameters unique 
to SBI: central obesity width and central obesity depth. It is of great significance that an 
assessment of visceral adiposity can be made by SBI, as it is very difficult to measure in a 
low-cost manner. These findings conclude that mathematical equations derived from 
body measurements obtained by SBI were sufficient predictors of visceral adiposity, the 
most difficult fat deposition to quantify without utilizing advanced techniques. 
The second aim was to determine body size and shape via total/regional body 
volume and volume ratios assessed by SBI in men and women. The body volumes and 
body volume ratios, including upper- and lower-body volume ratios, were measured to 
determine the body size and shape of men and women according to body mass index 
(BMI) classification and the risks associated with accumulation of visceral adiposity. 
Men showed higher total body (80.95 L vs. 72.41 L), torso (39.26 L vs. 34.13 L), and 
abdomen-hip (29.01 L vs. 25.85 L) volumes, and waist circumference (95.21 cm vs. 
88.46 cm), as compared to women. Women exhibited greater thigh volumes (4.93 L vs. 
3.99 L), hip circumference (112.56 cm vs. 106.68 cm), and lower body-volume ratios 
[thigh to total body (0.07 vs. 0.05), thigh to torso (0.15 vs. 0.11), and thigh to abdomen-
hip (4.93 vs. 4.00); p<0.05]. Thigh to torso [odds ratios (OR) 0.44] and abdomen-hip (OR 
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0.41) volume ratios were associated with decreased risks of accumulating visceral 
adiposity, even after age, sex, and BMI were taken into account. The innovation of this 
aim was to utilize the volumes in segments of specific regions of the body via SBI. The 
body measurements assessed via SBI provided an effective method for determining body 
size and shape in men and women, as well as for prediction of visceral adiposity 
deposition in both sexes. 
The third aim was to examine the efficacy of SBI for assessment of android and 
gynoid fat adiposity. Body circumferences, volumes, and volume ratios, as measured via 
stereovision body imaging, were utilized to develop mathematical models to predict 
android and gynoid fat mass and percent fat. The validity of these measures of adiposity 
was tested by comparisons to values that were determined by DXA. SBI body parameters 
that were used for independent variables consisted of ratios of waist to hip, waist to thigh 
circumferences; circumferences of waist, hip, upper thigh, lower thigh and knee; volumes 
of total body, torso, abdomen-hip, and thigh; volume ratios of torso to total body, 
abdomen-hip to total body, thigh to total body, abdomen-hip to torso, thigh to torso and 
thigh to abdomen-hip; as well as central obesity depth and width. Demographic 
parameters (age, sex) also were included as independent variables for the establishment 
of the prediction models.  
The prediction values of the mathematical equations for fat mass and percent 
body fat were 93.2% and 76.4% for android, and 91.4% and 66.5% for gynoid, 
respectively. The body measurements derived via SBI were more effective for creating 
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prediction models for android and gynoid fat mass, as opposed to fat percentages. The 
high prediction values for total and regional body fat mass indicated that the SBI is a 
reliable device that can be used for the estimation of body fat mass, but less so for body 
fat percentage. 
 
Conclusions and Future Directions 
Knowledge of specific shapes and sizes of bodies and segments, with varying 
distribution of total, central and regional fat distribution, may provide beneficial 
information regarding obesity-related risk factors. The utilization of SBI in the present 
research enabled the effective assessment of total, central, and regional adiposity for fat 
mass.  
An advantage of SBI is that it is an efficient and reliable instrument that can replace some 
traditional manual methods to measure various body composition (body circumferences, 
volumes and lengths) in a rapid manner without the awkwardness that results from the 
close proximity between the researcher and subject. SBI is easy to fabricate, as it is built 
with only four pairs of cameras and four projectors. This permits portability of the 
instrument and makes it ideal for large scale epidemiological studies that requires 
assessment of numbers of subjects in different locations. The use of SBI for assessment 
of body size and shape would be a paradigm-shift that provides more practical and cost-
efficient means than that currently available by CT, MRI or DXA. For example, the 
estimated cost for a SBI system is about $10,000, as opposed to several hundred thousand 
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dollars for other assessment instruments. The ability to accurately estimate total, central 
and regional adiposity, in particular, would provide health practitioners an enhanced 
ability to assess and monitor types of obesity.  
Nonetheless, a limitation of this research was the prediction values for total and 
regional (android, gynoid) body fat percentage (76.4% for android, 66.5% for gynoid), as 
compared to regional fat mass (93.2% for android, 91.4% for gynoid). The lower 
prediction values for total and regional percent body fat imply that better body 
measurements are required to establish mathematical models for body fat percentage.  
Only Caucasians and non-White Hispanics were included in the subject sample, 
which suggests that the prediction equations that were developed in this study may not be 
applicable for other ethnicities, such as Asians or African-Americans. Although SBI can 
be used in more broad ranges of BMI classification, only healthy weight, overweight, and 
obese class I participants were recruited in the study in order to form a homogenous 
group to reduce the variation within the group. This restriction was due to the funding 
limitations of the grants. Any inferences regarding body size and shape that were 
associated with age could not be made due to the small sample size within each age 
group. Moreover, inflammation or metabolic blood markers were not tested in this 
research, which made it such that researchers were unable to explore the direct 
associations between SBI assessed body composition or equations and obesity-related 
risk factors.  
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The future direction of 3D SBI would be to continue to refine the technique so 
that a better prediction of percent body fat could be achieved. Also, the research could be 
expanded to include a broader range of ethnicities, BMIs, and ages to explore the 
disparities of body size and shape in diverse populations. Particularly, it is believed that 
SBI could be used for monitoring infant/adolescence growth and development, tracking 
body size and shape after a patient is diagnosed with certain diseases, or following the 
application of a new therapy. Finally, monitoring body composition changes according to 
different types of physical activity (i.e. resistance training versus aerobic) would be 
helpful for researchers, as well as for the individuals. Knowledge of the precise change in 
body size and weight could be used as motivations for the individuals to pursue their 
goals for weight loss and/or maintaining a healthy weight. 
In summary, the long-term future of SBI is promising for the assessment of total, 
central (total abdominal, subcutaneous, visceral), and regional fat mass (android, gynoid), 
but less so for percent fat at this time. An improved understanding of human body 
composition was achieved through state-of-the-art 3D SBI and other advanced techniques 
(MRI, DXA, ADP) tested in this research. This information in this dissertation will 
provide guidance for researchers and health care practitioners in the assessment of 
obesity.  
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